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This thesis will present insights into natural type I collagen based upon studies 
with collagen mimetic peptides. Natural collagen is a fibrous protein with challenging 
properties, such as solubility, which makes it difficult to study through analytical 
methods such as nuclear magnetic resonance spectroscopy. Collagen mimetic peptides 
are a flexible and controlled model system that imitates natural type I collagen structure, 
a triple helix, on a smaller scale, from over 1000 amino acids to around 30 amino acids. 
Chapter one will explore the development of collagen mimetic peptides and review the 
current design principle to form composition and register specific triple helices. Chapter 
two will illustrate the power of charge pairing in the triple helix with the creation of a 
triple helix with an extended offset through axial charge pairing. This is the first triple 
helix with an extended offset, proving that the offset triple helix is possible, even when it 
is not incorporated into a fiber. Chapters three and four will model mutations from 
Osteogenesis Imperfecta, a type I collagen disease, in collagen mimetic peptides. 
Osteogenesis Imperfecta results from mutations of the requisite glycines in the Xaa-Yaa-
Gly repeat of collagen. Mutations in both the A and B chains of an AAB triple helix will 
be created, and their impact on the composition, stability, and structure of the triple helix 
will be examined through circular dichroism and nuclear magnetic resonance 
experiments. The results of those experiments will be used to create molecular models of 
the mutated triple helices. This series of studies gives insight into the forces in the triple 
	 ii 
helix: the destabilizing force of a mutation, the stabilizing force of hydrogen bonds, and 
the stabilizing, yet constricting, force of axial charge pairs. In these model systems, the 
mutation was able to direct the composition and register of the triple helix, where the 
triple helix with the lowest number of mutations would fold, even if it is not the most 
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Chapter 1: Introduction 
 
 
Natural type I collagen is a native hydrogel with numerous beneficial medical 
applications, such as wound healing,1 a scaffold for growth and regeneration of tissues,2 
and drug delivery.3 However, natural collagen grafts can have issues with immune 
response.4 In this review I will describe the recent work in the field of collagen mimetic 
peptides with a brief review of natural collagen as it relates to the sequence and 
properties of mimetic peptides. The many applications of natural collagen will not be 
discussed in detail, but more information can be found in the reviews cited above. 
1.1 Collagen Structure and Sequence 
 
Collagen is a complex protein that lends a range of properties to the extracellular 
matrix, such as strength and adhesion. This supramolecular complex forms large fibers, 
which create the scaffold for many tissues in the body. Each collagen fiber is composed 
of smaller fibrils, which in turn are composed of many individual triple helices.  Each 
triple helix has three protein chains, which wind together to create a superhelical 
structure.5 Each of these protein chains have a specific triplet repeat amino acid sequence, 
Xaa-Yaa-Gly, where Xaa and Yaa can be any amino acid, but every third amino acid 
must be a glycine or the structure will be disrupted.6 Glycine is essential because it is 
packed into the center of the triple helix, with the alpha hydrogens almost touching the 
adjacent chains. Each glycine can be packed into the center of the triple helix because of 
a one amino acid offset between the chains of the triple helix (Figure 1.1). This offset 
allows for one glycine to be present in each cross-section of the triple helix, and therefore 
packed into the center of that cross-section. Any other amino acid causes disruption due 
	 2 
 
Figure 1.1. Sequence (a) and model (b) of a collagen triple helix. The chains are offset 
by one amino acid and each follow the Xaa-Yaa-Gly repeat. The boxes show those 
specific cross-sections in the triple helix. (c) Model with space-filling glycine residues 
showing the proximity of the chains. 
 
 
to steric hindrance because it would have a side chain at that position that would disrupt 
the tight fold of the triple helix. 
The Xaa and Yaa positions can be any amino acid, but in natural collagen the Xaa 
position is dominated by proline (Pro, P), and the Yaa position hydroxyproline (Hyp, O). 
Hydroxyproline is a post-translational modification of proline in which a hydroxyl group 
is added to the gamma carbon of the proline ring. The Xaa position is most commonly 
proline where 32.9% of fiber-forming collagens triplets have proline in the Xaa position, 
but it is followed by glutamate at 13.0% and alanine at 11.0%.7 Overall, negatively 
charged amino acids are more common than positively charged in the Xaa position. The 
Yaa position is hydroxyproline in 34% of triplets, followed by arginine at 11.4% and 
	 3 
 
Figure 1.2. A) Sequence with hydrogen bonds shown. The A chain is repeated below the 
C chain to show those hydrogen bonds, because the triple helix is cylindrical a 2D 
projection is not adequate to illustrate the topology. B) Model of hydrogen bonds shown 
as yellow dashed lines in a triple helix. 
 
methionine and lysine both at 9.0%.7 In the Yaa position positively charged amino acids 
are more common than negatively charged amino acids.8,9  
The triple helix is non-covalently linked through hydrogen bonds.6,10,11 These 
hydrogen bonds are between a glycine of one chain, and the amino acid in the X position 
of an adjacent chain (Fig. 1.2). These hydrogen bonds are the major stabilizing force of 
the triple helix.  
1.2 Collagen Mimetic Peptides 
Collagen has an active role in various biological processes, acting as a scaffold, 
an active site for receptors, and a signaling protein.12 Studying collagen in the lab is vital 
to understanding how these processes work. However, natural collagen is a fibrous 
protein with solubility concerns except under harsh conditions. These harsh conditions, 
such as acid or heat, denature the protein, destroying the structure we wish to study. 
	 4 
 
Figure 1.3. Possible registers of specific compositions. 
 
 
Collagen mimetic peptides replicate the collagen structure on a much smaller 
scale, ~30 amino acids to the ~1000 amino acids in type I collagen. These shorter 
peptides are soluble, and can be synthesized with complete sequence control using solid 
phase peptide synthesis.13 SPPS allows sequences that are challenging to synthesize in 
bacterial systems such as modified amino acids,14 colorimetric labels,15 or isotopic 
labels16 to be incorporated into the synthetic peptides. The peptides self assemble into a 
triple helix replicating collagen structure.13 They can be used to study the properties and 
structure of collagen without the denaturation or complications of the natural system.16 
1.3 Design of Collagen Mimetic Triple Helices 
Collagen mimetic peptides can be designed to form distinct and specific folded 
triple helices.17-19 Each triple helix consists of three peptide strands which can have the 
same sequence, called a homotrimer, or it can have distinct sequences, called a 
heterotrimer.20 When a helix has three of the same chains it is called an AAA 
composition, and there can be AAB or ABC composition as well. Each strand must have 
the triplet repeat Xaa-Yaa-Gly, but variation in the Xaa and Yaa positions can be used to  
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Figure 1.4. All possible compositions and registers formed from three distinct peptide 
strands. 
 
favor specific triple helices. For example, a particular system has one positively charged 
peptide strand (PKG)10, one negatively charged strand (DOG)10, and one neutral strand 
(POG)10. When mixed together these peptides reliably fold into a triple helix in a 1:1:1 
ratio.21 
The one amino acid offset of the triple helix allows for distinction between the 
chains, and creates differences when the chains are in different orders in the triple helix.10 
For example, in a triple helix with three different peptide strands A, B, and C, different 
helices are created if the chains fold in the order ABC or BAC. ABC and BAC are called  
registers, or orders, of the peptides in the ABC composition triple helix, illustrated in Fig. 
1.3.20 
Since these collagen mimetic peptides self assemble there is a complex 
equilibrium when one, two, or three peptides are mixed together.20 If one register is very 
	 6 
favorable energetically, it will be the major assembly, but if multiple triple helices are 
favorable there will be many components to the solution. When three peptides are mixed 
together there are twenty-seven possible triple helices (Fig. 1.4). A specific composition 
and register could be required for a disease model or study of binding sites. Designing a 
triple helix requires consideration of all the alternate triple helices and comparing them to 
the target. 
In a triple helix, the most thermally stable triplet sequence is proline-
hydroxyproline-glycine.7 Any substitution away from these amino acids destabilizes the 
triple helix.7 However, simple POG triple helices cannot have a controlled composition 
and register, nor do they adequately reflect natural collagen, which has a wide range of 
amino acids. 
1.3.1 Single Amino Acid Substitutions 
Most amino acids have been studied for their individual impact on the stability of 
the triple helix. In this study a (GPO)3GPY(GPO)4GG host-guest peptide was used where 
individual substitutions were made in the Yaa position, the peptide was incubated, and 
the melting point of the resulting triple helix was measured.7  The most stable amino 
acids in the Y position were Hyp, Arg, and Met while the least stable were His, Asp, Leu, 
Asn, Tyr, Phe, and Trp (Fig. 1.5).7 Computational modeling indicates that stabilization 
from Arg and Met may be due to noncovalent interaction of the side chains with the 
backbone of the peptide chain. However, in the least stabilizing amino acids, branching at 
the delta carbon blocks solvent molecules from accessing the backbone, reducing the 




Figure 1.5. Sequence of Model systems. Melting points of selected substitutions from 
Persikov, et al 2000. 
 
 
A complementary system (GPO)3GPX(GPO)4 was used to do the same analysis 
with amino acids in the Xaa position. In the Xaa position Pro, Glu, Ala, Lys, Arg, Gln, 
Asp are the most stable (Fig. 1.5). The ionizable side chains of Glu, Lys, Arg, Gln, and 
Asp are available to hydrogen bonds with the backbone carbonyls or solvent molecules. 
Residues with branching at the delta carbon are less stable in the Xaa position when 
compared to the Yaa position. However, the most stabilizing amino acids are the imino 
acids, proline and hydroxyproline, where proline is the most stabilizing in the Yaa 
position and hydroxyproline is the most stabilizing in the Xaa position.7  
1.3.2 Paired Amino Acid Substitutions 
The single amino acid substitutions are isolated with only proline, 
hydroxyproline, and glycine available for interactions. However, with double 
substitutions additive effects between the amino acids can be explored. The base 
sequence (GPO)3GXY(GPO)4GG was used to test different combination of amino acids 
selected based upon the frequency of the triplet occurring in natural collagen. The 
homotrimeric triple helices were folded and the melting point of the helix was found.  
The triplets GPO, GER, GAR, GDR, GKD, GKE, GEK, GRD, and GRE had the highest 
melting points in excess of 33 °C (Fig 1.6).8 Seven of these nine sequences incorporate 
both a positive and negative amino acid. These charge pairs suggest a stabilizing 
Substitution GXO GPY 
Hyp  47.3 
Arg 40.6 47.2 
Met 38.6 42.6 
Ile 38.4 41.5 
Gln 40.4 41.3 





Figure 1.6. Sequence of the model system. Melting points of selected paired systems 
from Chan, et al 1997. 
 
interaction when both a positive and negative amino acid are present in the triple helix 
when compared to sequences with two uncharged amino acids. 
Further studies have refined the positional preferences of the positively and 
negatively charge amino acids showing a preference of negative residue for the Xaa 
position and positive amino acids for the Yaa position.8,22 Furthermore, the distance 
between the amino acids is also important. Utilizing the model system (GPO)3G-X-Y-G-
X’-Y’-(GPO)3GG, where X and X’ can be independently substituted, interactions where 
the amino acids were separated by three amino acids were studied. The guest sequences 
of GPKGEO and GPKGDO showed surprisingly melting points of 47.8 °C and 47.1 °C, 
respectively, drastically above the predicted values of 32.4 °C and 29.6 °C.23 The 
predicted melting points are calculated from the decrease in melting point from 
(GPO)8GG when a single lysine and a single glutamic acid is substituted (for GPKGEO). 
These predicted values should predict the melting point of the helix if there is no 
interaction or secondary effects of having two amino acids substituted. However, the 
triple helices were much more stable than the prediction, indicating interaction between 
these amino acids because they exceed the simple additive prediction of the stability of 
the triple helix. 
Substitution Tm °C Substitution Tm °C 
GPKGEO 47.8 GDKGPO 30.9 
GEOGPK 38.0 GDRGPO 37.1 
GPKGPE 36.5 GEKGPO 35.0 
GPKGDO 47.1 GERGPO 40.4 
GPRGDO 39.6 GKEGPO 35.3 
GPRGEO 42.8 GKDGPO 35.8 
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Figure 1.7. Sequence and model illustrating axial(a,c) and lateral(b,d) charge pairs. 
 
 
1.3.3 Charge Pairing 
Interactions of two oppositely charged amino acids in the triple helix are called a 
charge pairs. The orientation and identity of the amino acids determines the energetic 
benefit of the pair. Two common orientations are lateral and axial charge pairs.24 The 
lateral charge pair consists of a positively charged amino acid that is one position over in 
the sequence on an adjacent chain from a negatively charged amino acid. The amino 
acids are aligned in the triple helix, essentially standing out from the helix next to one 
another, and the positively charged amino acid leans over to interact with the negatively 
charged side chain (Fig. 1.7).25 Axial charge pairs are formed between a positive amino 
acid in the Yaa position reaching down to a negatively charged amino acid in the Xaa 
position of the next triplet in an adjacent chain (Fig. 1.7).25 These charge pairs are 
typically have a lysine as the positive amino acid and glutamic acid or aspartic acid as the 
negatively charged amino acid.20 Axial interactions have been shown to direct the folding 
of triple helices, with the ability to make composition and register specific triple helices 
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as well as staggered triple helices with more than the typical one amino acid 
offset.17,19,26,27  
1.4 Creating Composition and Register Specific Triple Helices 
The design possibilities for heterotrimeric triple helices are far greater than 
homotrimeric triple helices, simply because there is a much larger sequence space with 
two or three distinct chain sequences. One could imagine recreating active sites from 
natural collagen, creating topologically distinct scaffolds, or unique biomimetic 
sequences. Heterotrimers offer unique design possibilities, but come with a complex set 
of design rules that are still not fully understood. 
1.4.1 ABC Triple Helices 
Heterotrimeric design started with bulk attraction and repulsion of positive and 
negative charges. A triple helix was designed with ten positively charged resides, 
(PRG)10, a peptide with ten negatively charged residues, (EOG)10, and a neutral peptide 
(POG)10.28 This system showed a distinct triple helix formed only when the three peptides 
were mixed together, that was not present in a mixture of two of any of the three 
component peptides. This helix has a melting point of 54 °C while (POG)10 had a melting 
point of 67.5 °C under the same conditions.29 Expanding on this study, (DOG)10, 
(EOG)10, (PRG)10, and (PKG)10 were all assessed to find the most stable combination of 
positive and negative amino acids. They found the most stable combination was (PKG)10, 
(DOG)10, (POG)10 with a melting point of 65 °C which is surprisingly only depressed 2.5 
°C from (POG)10 when compared to the mixture of just (PKG)10 and (DOG)10 which 
melts at 36 °C.28 
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The most stable of these triple helices ((PKG)10, (DOG)10, (POG)10) was 
examined further with x-ray crystallography and nuclear magnetic resonance 
spectroscopy (NMR).30 Through this experiment, it was found that the lysine and 
aspartate side chains form an axial charge pair across the triple helix, enabling the 
specific formation of one composition and register in solution. Seeing this as a design 
tool, axial charge pairs were utilized to computationally design an ABC composition and 
register specific triple helix. 
This use of axial charge pairs to specify composition and register spurned a new 
area of study where a specific triple helix can be rationally designed. Axial charge pairs 
have been used to design AAB and ABC composition and register specific triple helices, 
triple helices that lack hydroxyproline, composition and register specific disease 
models.18,19,21,26,31,32  
1.4.2 AAB Triple Helices 
The creation of AAB composition and register triple helices also utilized axial 
charge pairs.18 The sequence space of AAB composition helices is limited because one 
chain repeats; typically leaving unpaired charged amino acids, and less sequence space. 
AAB helices are important because they are the same composition as collagen type I, 
therefore can be used in disease models.12 
The AAB composition has been achieved by designing a helix with a net neutral 
charge, but with individual peptides that have an overall charge. Specifically the system 
(PKGPOG)5 and (EOG)10 mixed in a 2:1 ratio gives a net neutral helix.33This triple helix 
was also observed to have axial charge pairing by NMR. However, two registers of this 
system where present, (PKGPOG)5 (EOG)10 (PKGPOG)5 and (PKGPOG)5 (PKGPOG)5 
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Figure 1.8. Found registers of the (PKGPOG)5 (EOG)10 system. Amino acids in axial 
charge pairs shown in grey, while unpaired amino acids are shown in yellow. 
 
 
(EOG)10. Both registers have the same amount of charge pairs, and unpaired amino acids 
(see Fig. 1.8). In order to have register control, this design must be adjusted to stabilize 
one specific register over the other.33 
For an AAB composition and register specific sequence, a triple helix was 
designed where the AAB register was stabilized over the other registers.18 This was 
created by taking a homotrimer sequence (PKGXOG)5 (where X is aspartate or 
glutamate) and removing charged amino acids that would not be charge paired in the 
triple helix. The resulting helix which consists of two (PKGXOG)5 strands and one 
(POGXOG)5 strand, alternatively the negatively charged amino acid could be replaced 
with positively charged amino acids resulting in (PKGXOG)5 and (PKGPOG)5. Of these 
systems only (PKGEOG)5-(POGDOG)5 and (PKGDOG)5-(POGDOG)5 were found to 
form composition specific heterotrimers in solution. However, only the (PKGEOG)5-
(POGDOG)5 was found to form a single AAB triple  helix in solution. (PKGDOG)5-
(POGDOG)5 was composition, but not register specific.18 
1.4.3 Hydroxyproline and Proline Effects 
Proline, the only imino acid, and its post-translational modification, 
hydroxyproline, are ubiquitous in collagen.7 Their ringed structure is predisposed to the 
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Figure 1.9. (a)Sequence and charge pairs of hydroxyproline-free triple helix. (b)Thermal 
denaturation monitored by CD of all possible component triple helices. Figure adapted 
from Jalan et al, 2013. 
 
 
poly-proline type II secondary structure with phi and psi angles of -75° and 150°, 
respectively, and they lend stability to the triple helix.34 However, when designing and 
producing triple helices they can be problematic. Their presence in a triple helix is 
stabilizing to all compositions and registers regardless of the sequence unlike charged 
amino acids that are destabilizing without an oppositely charged partner in the correct 
position. This creates challenges in complicated composition and register control because 
the constituent peptides may form homotrimers or undesired heterotrimers if they are 
stable enough to compete with the target state. Beyond design concerns, a typical method 
of producing proteins is through bacterial expression. Most bacteria do not posses the 
enzyme proyl hydroxylase which converts proline to hydroxyproline,35 and even if they 
did there is currently no way to signal hydroxylation at specific prolines. 
While hydroxyproline is highly stabilizing to a triple helix, the use of axial charge 
pairs allows a triple helix to be formed without it. This design with eighteen charge pairs 
and no hydroxyproline melts at 37 °C. It is an ABC composition triple helix of (PKG)10, 
(DKG)10, and (EPG)10 (Fig. 1.9).26 None of the alternate compositions form in part 
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because alternate compositions would have a net charge, with the exception of the 
homotrimer of (DKG)10, which is inherently destabilized with no proline or 
hydroxyproline. This triple helix is the first collagen mimetic triple helix without 
hydroxyproline.26  
1.4.4 Design Principles 
Currently, the design of triple helices can be governed by a few principles. First, 
eliminate unpaired charged amino acids. Having unpaired charged amino acids in the 
final design decrease the specificity of the target system, not just by destabilizing the 
target system, but also by potentially participating in charge pairs in other compositions 
and registers, increasing the stability of those species. Secondly, when creating charge 
pairs lysine-aspartate pairs are more stabilizing to the triple helix than lysine-glutamate 
charge pairs. However when designing a composition and register triple helix, it must be 
kept in mind that all lysine-aspartate charge pairs will be stabilizing to the alternate 
composition and registers as well. At times a mixture of lysine-aspartate and lysine-
glutamate pairs is useful to strike the balance between stability and specificity. The last 
strategy to increase the specificity of a single composition and register is to change the 
hydroxyprolines to prolines in the peptide strands that are forming the alternate helices. 
This will destabilize the alternate helices and the target helix, but if the original helix was 
stable enough, the correct composition and register will fold. 
1.5 Applications of Collagen Mimetic Peptides 
Collagen mimetic peptides are a malleable model system for natural collagen. By 
adjusting the amino acid sequence, triple helices can be made for specific modeling of 
disease states, for example the disease Osteogenesis Imperfecta,36 substrates for studying 
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enzymatic activity37 or targeted adhesion to damaged collagen,15 or for the creation of 
unique supramolecular structures including fibers and nanosheets.38-41  
1.5.1 Osteogenesis Imperfecta 
Osteogenesis Imperfecta is a disease which disrupts the canonical folding of the 
collagen triple helix,6,10 specifically the hydrogen bonds that form between the backbone 
of the different chains. This disease results from mutations to the amino acid sequence of 
type I collagen, the most harmful of which is to the glycine of the repeating Xaa-Yaa-Gly 
motif. These mutations result in an array of phenotypes, ranging from easily broken 
bones to fatality in utero.42,43 This array of phenotypes results from substitutions of 
diverse amino acids at many possible mutation sites.  
From prior studies we know there are a few rules governing the impact of an OI 
mutation.44 First, the identity of the substituted amino acid is somewhat predictive of the 
lethality of the mutation. There are seven most common substitutions alanine, serine, 
cysteine, valine, aspartate, glutamate, and arginine. The lethality of the mutations is Val 
>Asp >Glu >Arg >Cys >Ser >Ala for the alpha1 chain and Glu >Asp >Cys >Arg >Val 
>Ser >Ala for the α2 chain,42 which is the same as the trend seen in model systems.45 In 
systems where there is a possibility of the substituted side chain hydrogen bonding seen 
in serine mutations, there can be a stabilizing effect of the side chain hydrogen bonding to 
the backbone of the other chains.46,47  Secondly, the mutation could appear in both α1 
chains or just the α2 chain, where the two mutations have a greater degree of disruption 
than one.42,48 Third, the rigidity of the surrounding amino acids affects the ability of the 
triple helix to renucleate after disruption.49,50  
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Lastly, the location of the mutations within collagen sequence can have an effect. 
If the mutation occurs close to a binding region the mutation would be more lethal, and 
the mutations close to the N-terminus are less impactful than the mutations close to the 
C-terminus.42,43,51  
Previous model systems have elucidated the loss of stabilizing hydrogen bonds in 
the mutated triple helix.  A (POG)4POA(POG)5 homotrimeric crystal structure has shown 
four backbone hydrogen bonds lost.52 Subsequent NMR studies have shown two 
hydrogen bonds lost in the solution state.46 These systems were both homotrimeric triple 
helices, which do not directly reflect the natural AAB composition of type I collagen.53 
The first study, which displayed a mutation in a heterotrimeric triple helix, was in 
a ABC composition system.54 A guest region was incorporated with an AAB composition 
and that region contained mutations in one, two, or three chains. Unfortunately that study 
only included Circular Dichroism (CD) analysis, which cannot give register information. 
However, this study was able to show that the first mutation to the triple helix was the 
most impactful, with subsequent mutations having a smaller effect. 
Other collagen types have been studied, for example type IV with interruptions to 
the canonical X-Y-Gly triplet. It was a heterotrimeric system with disruptions in both 
chains, namely a glycine deletion in the A chain and a glycine to leucine mutation in the 
B chain. This study surprisingly saw controlled composition and register without charge 
pairs, and the concluded that the mutations had an impact on the register and 
composition.55 
1.5.2 Fiber Forming Peptides
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The natural collagen fiber is a complex supramolecular assembly with forces 
elongating the triple helix as well as forces assembling the triple helices side-by-side 
resulting in a wide and long fiber. Natural fiber formation is controlled by globular 
domains at the ends of the collagen protein strands which are later cleaved.12 However, in 
collagen mimetic peptides globular domains would be too large and dominate the 
secondary structure, so other assembling forces must be used. Commonly these fibers are 
assembled through the used of charge pairing, however a group has reported fiber 
formation with the use of pi-pi stacking interactions.40  
Beyond fiber formation, a true collagen mimic would have aligned and organized 
fibers. In natural collagen this alignment is evident in the d-periodicity of the fibrils. Only 
one group has succeeded in creating d-periodic collagen mimetic fibers, which they were 
able to grow to a length of 3-4 micrometers and a width of 12-15 nanometers. However 
these fibers, were only d-periodic in a specific buffer system, and had a low melting point 
between 37 and 48 °C depending on the buffer system.38  
Other fiber forming peptides result in hydrogel formation, which could have a 
wide range of translational applications as scaffolds for bone formation, hemostats, and 
wound healing. These hydrogels are formed utilizing axial charge pairs, which stabilize 
and direct the assembly.56 In some cases they are also hypothesized to offset the peptide 
strands, resulting a sticky-ended intermediate that catalyzes fiber formation.39,41 
1.5.3 Alternate Supramolecular Structures 
Beyond fibers, other supramolecular structures, specifically sheets, have been 
formed by modification of the collagen mimetic peptide sequence. These sheets can be 
formed by peptides with positive, negative, and neutral regions that form triple helices 
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and pack in an antiparallel fashion, matching a positive region to a negative region.57 In 
the most controlled and homogenous sheets, the positive region utilized aminoproline 
(both the 4R and 4S version), an unnatural amino acid. Sheets can also be formed by a 
mixture of positively charged triple helices and negatively charged triple helices leading 
to matching oppositely charge tips aligning in an upright fashion, as hypothesized by the 
researchers.58 A two-peptide composite has also been used to form multilayered sheets of 
positive and negative triple helices. Both of these sheet structures needed arginine to 
mediate the helix-helix interactions, and there was no supramolecular structure formed 
when lysine was used.59,60  
1.5.4 Biological Applications 
Collagen mimetic peptides have been used extensively to study interaction with 
other proteins and enzymes. Toolkits have been designed from the sequences of type I, II, 
and III collagen where the sequences are broken up into twenty-seven amino acid chunks 
with overlapping regions on the tips.61 These toolkits have been used to interrogate 
binding sites in collagen with a range of proteins such as integrin α2β1, platelet receptor 
Gp VI, plasma protein vWF, a tyrosine kinase receptor DDR2, and basement membrane 
protein BM-40. These studies elucidate binding sites like GXYGER motifs with integrin 
α2β1.61 
Collagen mimetic peptides have also been used as a model system to study the 
activity of matrix metalloproteases (MMP),37 which cleave proteins including collagens. 
Short collagen mimetic peptides with native collagen sequences were used to elucidate 
the cleavage site of hundreds of MMPs. These studies were also expanded to examine the 
relative rates of MMP activity against the mimetic peptides.62 
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1.6 Conclusions and Preview of Thesis 
The collagen mimetic peptide is a versatile model system and building block for 
supramolecular assembly. This class of peptides has a well-understood synthesis and the 
design principles, while not complete, can be used to design specific and reproducible 
triple helices. With improvements in the stability of the heterotrimeric triple helix, these 
peptides have the potential to be an important model system in understanding collagen’s 
role in biological processes.  
In this thesis I will present improvements in the collagen mimetic peptide model 
system. In Chapter 2, I will discuss innovations in the design of collagen mimetic 
peptides. Axial charge pairs were used to create longer offsets in a triple helix, increasing 
our understanding of the stability conferred by charge paring. This study differentiates 
the stability of axial and lateral charge pairs, where axial charge pairs are found to be 
more stabilizing than their lateral counterpart. In this chapter, experiments were designed 
by Dr. Jalan and Prof. Hartgerink, with peptides synthesized by Dr. Jalan and I. I 
performed purification and CD studies, as well as a portion of the NMR spectra 
collection, with the rest completed by Dr. Jalan. Dr. Jalan, Prof Hartgerink, and I 
analyzed the data and prepared the manuscript. 
In Chapter 3, I will discuss the development of a self-assembling AAB 
composition and register controlled model of the disease Osteogenesis Imperfecta. Here I 
will focus on mutations to the B chain of the AAB triple helix. This model is the first 
collagen mimetic triple helix that incorporates a mutation like those seen in Osteogenesis 
Imperfecta while folding into a designed composition and register. In chapters 3 and 4 the 
studies were conceived and designed by Amanda Acevedo-Jake, Prof. Hartgerink, and 
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myself. Amanda Acevedo-Jake and I split the synthesis and purification of the peptides, 
while I completed CD analysis. Amanda Acevedo-Jake collected and analyzed the NMR 
spectra, while I translated the spectra to models using Rosetta. Amanda Acevedo-Jake, 
Prof. Hartgerink, and myself analyzed the data and prepared the manuscripts. In Chapter 
4, Douglas Walker created the algorithm to calculate helical twist and assisted in analysis 
of that data. 
In Chapter 4, I will expand on the model developed in Chapter 3 with mutations 
to the A chain of the AAB triple helix. These mutations resulted in disruptions to the 
composition and register of the model, the first time composition disruption has been 
reported as the result of mutations to glycines in the triple helix. This disruption was 
explored further with mutations in both the A and B chains of the AAB triple helix, 
which was found to fold with controlled composition and register. This study also 
developed a new parameter to analyze the triple helical topology called helical twist. 
These studies have contributed a new understanding to the forces stabilizing and 
destabilizing the triple helix.  
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In DNA origami,1 the adenine−thymine and guanine−cytosine nucleotide pairing 
is used to create sticky-ended motifs that self-assemble into complex nanostructures.2-4 
Similarly, in α-helical coiled-coil design, interactions between side chains of acidic and 
basic amino acids patterned at the e and g positions of the abcdefg heptad repeat 
introduce offset in an otherwise blunt-ended oligomer and nucleate fiber formation.7,8 
Therefore, design of protein folds containing unsatisfied polar or electrostatic contacts at 
the N- or C-termini is of interest from a supramolecular assembly perspective. Sticky-
ended motifs can be routinely designed for DNA and α-helical coiled coils. Although a 
covalently linked sticky-ended collagen triple helix has been reported before,9 proof-of-
principle design of a non-covalently self-assembled sticky-ended collagen triple helix has 
remained elusive. Here we use axial salt-bridge interactions to place the three peptides of 
a collagen triple helix in a non-canonical four-amino-acid offset. The sticky ends are 
short and do not promote fiber formation, which allows us to confirm the intended 
molecular arrangement within the triple helix.  
In a collagen triple helix, three peptides containing Xaa-Yaa-Gly triplet amino 
acid repeats supercoil, with a one-amino-acid offset between the peptide chains. The one-
																																																								*	This chapter was adapted from  Jalan, A.A; Jochim, K.A.; Hartgerink, J.D.; “Rational 
Design of a Non-Canonical “Sticky-Ended” Collagen Triple Helix” J. Am. Chem. Soc. 
2014, 136, 7535-7538. 
 
This paper was published under the thesis author’s maiden name of Jochim.  
 
KAJ and AAJ synthesized, purified, and collected NMR data. KAJ performed CD 
analysis. KAJ, AAJ, and JDH analyzed the data and wrote the manuscript.	
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residue offset maximizes inter-peptide hydrogen bonds and optimizes helical packing.10 
Gly residues form the helical core, and therefore higher order assembly of the triple 
helices can only be mediated by patterning residues in the solvent-exposed Xaa and Yaa 
positions.11 Using short peptides that mimic the triple-helical protein fold of native 
collagen, we recently elucidated sequence rules for interpeptide salt-bridge interactions 
between a Yaa- positioned Lys and an Xaa-positioned Asp or Glu residue.12 We call 
these “axial” salt-bridges, as both side-chain conformations are approximately coaxial 
with the helical axis. Each Gly residue of the triple helix defines a cross-sectional plane 
that also contains the Xaa and Yaa residues of the other two chains. In terms of sequence 
position, an axial salt-bridge forms between the Lys in the nth and the Asp or Glu in the 
n+3 cross-sectional plane. The energetic stabilization derived from the interaction 
between Lys and Asp/Glu residues present within the same cross-sectional plane, which 
we call a “lateral” interaction, has been shown to be conformationally less robust than an 
axial salt-bridge.13 
Scheme 2.1. Sequences of non-canonical offset ABC-1 and canonical offset ABC-2 
heterotrimers, indicating positions of Lys−Glu axial salt-bridges. Grey highlighted area 
indicates the core region, which is identical in both triple helices. 
We have used axial salt-bridges to design AAA-,14 AAB-15,16 and ABC-type 17-19 
collagen triple helices. Of particular interest here is the peptide (PKG)4(POG)4(DOG)4 
that rapidly self- assembles into long fibers and ultimately a hydrogel in aqueous 
solution.14 To explain the rapid self-assembly, it was proposed that the peptide forms a 
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transient homotrimeric collagen triple helix with a 20-amino-acid offset between the 
peptide chains. The unusually long offset would contain numerous unsatisfied hydrogen-
bonding partners as well as unpaired and electrostatically charged Lys and Asp residues, 
which could drive rapid aggregation. However, due to the fibrous morphology of the 
aggregates, the offset within the collagen triple helix could not be elucidated using any 
biophysical tool available. Control over peptide offset in a triple helix has the potential to 
provide unprecedented control over its supramolecular fate. Therefore, in this chapter we 
demonstrate a proof-of-principle design of a collagen triple helix, ABC-1, with a four-
residue offset between the peptide chains (Scheme 2.1). The short offset reduces the 
likelihood of aggregation, allowing us to study its structure and stability in molecular 
detail by NMR. A second collagen triple helix, ABC-2, with identical amino acid 
composition but containing a one-amino-acid offset, is also designed. These two systems 
demonstrate our ability to modulate chain offsets in a collagen triple helix and lay the 
groundwork for design of a new class of collagen-related nanostructures.  
2.2 NMR and CD Analysis of ABC-1 and ABC-2 
Assuming a canonical single-amino-acid offset between peptides, a mixture of 
three peptides, A, B, and C, can self- assemble into 27 unique triple helices. Axial 
Lys−Asp/Glu salt- bridges have been used to bias the ensemble of competing states to 
selectively populate one AAB-16 or ABC-type17 heterotrimer of desired chain 
composition and register. In the case of ABC-1, we placed Lys and Glu residues such that 
they only form axial salt-bridges if the peptide chains adopt a four- residue offset, 
therefore setting the stage for an offset or sticky- ended assembly.  
The thermal melting curve of ABC-1 shows a broad transition with a major  
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Sequence Abbreviation Tm °C 
WG(POGPKG)2POGPKG(POGPKG)2 A1 - 
WG(PKGPOG)2PKGPOG(PKGPOG)2 A2 - 
WG(PKGEOG)2PKGEOG(PKGEOG)2 B 32 
WG(EOGPOG)2EOGPOG(EOGPOG)2 C1 45 
WG(POGEOG)2POGEOG(POGEOG)2 C2 42 
WG(POGPKG)5/ WG(PKGEOG)5 A1B 36 
WG(PKGPOG)5/ WG(PKGEOG)5 A2B 39 
WG(PKGEOG)5/ WG(EOGPOG)5 BC1 44 
WG(PKGEOG)5/ WG(POGEOG)5 BC2 41 
WG(POGPKG)5/ WG(EOGPOG)5 A1C1 m 
WG(POGPKG)5/ WG(POGEOG)5 A2C2 m 
WG(POGPKG)5/WG(PKGEOG)5/ WG(EOGPOG)5 ABC-1 47 
WG(POGPKG)5/WG(PKGEOG)5/ WG(POGEOG)5 ABC-2 52 
Table 2.1. Sequences, Abbreviations, and Melting Temperatures of Triple Helices 
Studied. Bold glycines indicate 15N isotopically labeled amino acids. M indicates a broad 
melting transistion. 
unfolding event at 47 °C (Figure 2.1a). In addition to a substantial decrease in van der 
Waals surface area, ABC-1 loses four inter-peptide hydrogen bonds at the termini due to 
the four-residue offset. The resulting conformational disorder is expected to result in a 
broader thermal transition, as terminal regions unfold before the more stable core of the 
triple helix. In comparison, ABC-2 shows a cleaner thermal transition, with a higher Tm 
value of 52 °C (Table 2.1). 
Due to the difference in hydrogen bonds formed by the 15N- Gly amide protons, 
each of the competing triple-helical states in a mixture of three peptides yields a 
fingerprint spectrum in a 1H,15N heteronuclear single-quantum coherence (HSQC) 
experiment. The HSQC spectra of ABC-1 shows three trimer cross-peaks labeled T1, T2, 
and T3 (Figure 2.1d), which do not overlap with cross-peaks of individual peptides or 
their binary mixtures. This suggests that mixing peptides A1, B, and C1 results in only 
one triple helix of A1·B·C1 composition. Additionally, the presence of only three trimer 
cross-peaks suggests that the three peptides in ABC-1 are arranged in only one register. 
Similar conclusions can be drawn from the HSQC spectra of ABC-2 and its component 
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Figure 2.1. (Top) First-derivative plots of thermal unfolding curves of (a) ABC-1 and (b) 
ABC-2 overlaid with those of component peptides (shown in black) and (c) overlay of 
ABC-1 and ABC-2 spectra. (Bottom) 1H,15N-HSQC NMR spectra of (d) ABC-1 and (e) 
ABC-2 overlaid with those of component peptides (shown in black) and (f) overlay of 
ABC-1 and ABC-2 HSQC spectra, demonstrating the similarity of two of the three N−H 
peaks. Monomer peaks are indicated within the box.  
peptides in Figure. 2.1e.  As shown in Figure 1f, two trimer cross-peaks in the HSQC 
spectra of ABC-1 and ABC-2 have very similar chemical shifts. A comparison of their 
amino acid sequence in Figure 2.3 indicates that two of the three inter-peptide hydrogen 
bonds formed by 15N- Gly(NH) are between identical sets of amino acid triplets. In 
contrast the third hydrogen bond is formed between dissimilar triplets, which explains the 
observed overlap in only two of the three cross-peaks. Importantly, if the ABC-1 were to 
adopt a canonical one-residue offset, all three hydrogen bonds, and therefore HSQC 
peaks, would be chemically distinct from those of ABC-2, and no cross-peak overlap 
would be expected. This result provides the first molecular-level evidence for the four-
residue chain offset in ABC-1.  
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Figure 2.2. (a) Sequence, (b) 15N-edited-NOESY spectrum, and (c) model of ABC-1 
indicating absence of inter-peptide 15NH−15NH (red lines) and 15NH−Hα (blue lines) 
NOE cross-peaks due to >6 Å separation between the protons. (d) Sequence, (e) 15N-
edited-NOESY spectrum, and (f) model of ABC-2 indicating absence of inter-peptide 
15NH−15NH (red lines) and 15NH−Hα (blue lines) NOE cross-peaks due to >6 Å 
separation between the protons. 
Additional evidence for the intended chain offset comes from homonuclear 
correlation NMR experiments. A two-dimensional 1H−1H plane of the three-dimensional 
1H,15N-NOESY- HSQC experiment (hereafter called edited-NOESY) shows nuclear 
Overhauser effect (NOE)-based cross-peaks between 15N-Gly(NH) and protons within ∼6 
Å of it. Since the intensity of the cross-peaks varies as 1/r6, where r is the spatial distance 
between the correlating protons, generally no cross-peaks are observed at distances 
greater than 6 Å. Due to the four-residue offset in ABC-1, the 15N-Gly amide protons of 
the A1, B, and C1 chains are more than 11.5 Å apart (Figure 2.2a). As a result, the edited-
NOESY spectrum of ABC-1 shows no cross-peaks for correlations between the amide 
protons (Figure 2.2b, red dotted circles). Additionally, 15N-Gly amide protons are also 
placed more than 10 Å apart from Hα of the residues preceding 15N-Gly of another chain. 
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Figure 2.3. Comparison of the hydrogen bonds formed by the 15N-Gly residues (shown in 
green) in ABC-1 in a non-canonical (a) and ABC-2 in a canonical (b) offset. Peptides in 
ABC-1 arranged in a hypothetical canonical offset are shown in (c) for comparison. Cyan 
and red boxes indicate identical chemical environment of 15N-Gly in chains A1 and B of 
ABC-1 and chains A2 and B of ABC-2. 15N-Gly residues in dissimilar chemical 
environment are shown within black boxes. 
As expected, these 15NH-Hα correlations are also not observed (Figure 2.2b, blue dotted 
circles).  
Analysis of the edited-NOESY spectra of ABC-2 confirms that the absence of 
NOE cross-peaks in ABC-1 is not an experimental artifact. As shown in Figure 2.2d, the 
N-15Gly’s of A2, B, and C2 chains of ABC-2 heterotrimer are within the observable NOE 
distance of 6 Å. Therefore, both 15NH−15NH and 15NH−Hα correlations are observed in 
its edited-NOESY spectra (Figure 2.2e). The accompanying homology model in Figure 
2.2f, built from PDB 2KLW,12 indicates the observed NOEs.  
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Figure 2.4. CD thermal melting profile of individual, binary and ternary peptide mixtures 
used for testing A1, B and C1 . 
The peptides A2, B, and C2 can arrange in six different ways within the ABC-2 
heterotrimer, but pairing of all Lys and Glu residues is only possible in one of them. 
Comparison of the observed 15NH−15NH and 15NH−Hα correlations to those expected in 
the six possible peptide arrangements in Table 2.2 confirms that the register of A2, B, and 
C2 shown in Scheme 2.1 is correct, allowing all Lys and Glu residues to form salt-
bridges.  
Similarly, the relative chain arrangement in ABC-1 depicted in Scheme 2.1 is 
critical for salt-bridge formation. To determine the peptide positions in ABC-1, we 
compared its two- dimensional 1H,1H-NOESY spectra to that of ABC-2. Due to identical 
triple-helical core regions, their NOESY spectra are nearly identical, indicating similarity 
in chain arrangement within the triple helix. Furthermore, a NOE cross-peak between 
E(NH) and K(Hε), characteristic of an axial salt-bridge,13,19 is observed in the
NOESY spectra of both heterotrimers. These results strongly suggest that the relative 
positions of peptide chains in both heterotrimers are as shown in Scheme 2.1.  
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Figure 2.5. 1H,15N-HSQC spectra of ABC-1 one week (left) and three month (right) after 
mixing A1, B and C1 peptides. The competing heterotrimeric peptide mixture A1C1 is 
shown in red. The monomer cross peaks are shown in the box. 
2.2.1 Direct Evidence of Offset 
In order to conclusively demonstrate the sticky- ended four residue chain stagger 
in ABC-1, we designed a related system ABC-1’. In this heterotrimer, chain C2 with the 
WG(EOGPOG)5 sequence is replaced with C2’ with sequence WG(EPGPPG)5. ABC-
1takes nearly three months to achieve single composition and single register and before 
this time the principle competing state is a binary mixture of A1 and C1. A comparison of 
the various AAB-type heterotrimers possible in a mixture of A1 and C1 revealed that the 
AAB composition containing two WG(EOGPOG)5 chains would the most stable. 
Therefore, we reasoned that a Hyp to Pro substitution in WG(EOGPOG)5 chain should 
destabilize this competing state and enhance the kinetics of ABC-1’ formation. Fig. 2.4 
and 2.5 below shows the results of HSQC and CD experiments. The HSQC shown in Fig. 
2.4 was acquired two weeks after annealing and shows ABC-1’ to be major species with 
a small population of competing triple helices. In addition to the substitution of Hyp for 
Pro, we also moved the 15N-Gly to a new position indicated in Fig. 2.6. The new position 
allows us to observe at least one set of NOE between the 15N- Gly of the middle chain 
and Hα of the lagging chain which confirms the four residue offset within the ABC-1’  
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Figure 2.6. a) Position of 15N-Gly labels in ABC-1’ shown in green, b) HSQC spectra of 
ABC-1’ acquired on a higher field 750 MHz Bruker cold probe to improve chemical shift 
dispersion, c) two dimensional 1H-1H version of the 3D-edited-NOESY indicating 
significant overlap in the amide proton chemical shifts of the three 15N-Gly, d) 1H-1H 
plane of a three dimensional edited-NOESY experiment at the 15N-chemical shift 




Table 2.2. Comparison of the observed 15NH-15NH and 15NH-Hα NOE correlations in 
ABC-2 to those expected from the six possible registers. Check marks indicate that the 
expected cross peak is observed while the X marks indicate otherwise. 
system. A second NOE between 15NH- 15NH could not be assigned due to spectral 
crowding. Since, ABC-1’ and ABC-1 are similar except for the substitution of Hyp for 
Pro, these results provide very strong evidence for a four residue offset in ABC-1.2.3 
Conclusions  
The ABC-1 heterotrimer can putatively form 10 lateral salt- bridges while
maintaining a canonical single-residue offset. Instead, our data suggest that the peptide 
chains in ABC-1 adopt a four-residue offset that sacrifices four hydrogen bonds at the 
termini in addition to significant van der Waals contact area to allow the formation of 10 
axial salt-bridges. This demonstrates a clear energetic preference of axial over lateral salt-
bridges. A similar preference for an axial salt-bridge has been demonstrated in systems 
where both contacts are feasible.12 It has also been shown that Lys and Asp/Glu residues 
in lateral positions are conformationally frustrated due to favorable backbone polar 
contacts.13 Although lateral interactions have been used in heterotrimeric design,20,21 the 
results presented here add strong evidence of the dominance of axial interactions over 
lateral ones.  
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Characterization of supramolecular polymers is typically limited to relatively low 
resolution techniques such as AFM and TEM, leaving the exact mechanism of assembly 
vague and open to debate. This makes improvement and modification of these systems 
more difficult. Here we have created a model system of a sticky-ended collagen helix 
which, while having offset termini, does not continue assembling due to the relatively 
short, four- amino-acid stagger. This has allowed us to examine the structure by NMR 
and reveal the individual amino acid interactions responsible for the structural 
organization. Our study gives molecular-level evidence for axial salt-bridge-driven 
formation of a sticky-ended collagen triple helix for the first time. The design can be 
readily adapted to create collagen triple helices with longer offset ends that hybridize into 
higher order fibrillar assemblies. Failure to observe a lateral salt-bridge-driven canonical 
triple helix indicates that axial salt-bridges are better suited for controlling self-assembly 
of collagen triple helices.  
The design of triple helices becomes an increasingly challenging topic as the 
number of possible alternative structures is considered. Moving from a homotrimer to a 
canonical ABC heterotrimer increases the number of reasonable structure from 1 to 27. 
An ABC system that makes non-canonical, sticky-ended structures feasible increases the 
number of competing structures to well over 100, even if only one triplet of overhang is 
considered. By increasing the length of the overhang, more competing states can be 
populated resulting in a rougher folding landscape, which in turn increases the time of 
folding. The effect of this is to roughen the folding landscape and therefore substantially 
increase the time of folding. From one perspective, the folding time may eventually make 
even well-designed systems impractical. From another perspective, in truly well-designed 
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systems, this additional challenge will be taken to heart, and negative design strategies 
will be used to engineer the folding landscape.  
 
2.4 Experimental 
ABC-1 and ABC-2 are identical with respect to the triple- helical core (see 
Scheme 2.1, shaded area), which facilitates comparison of their stability and molecular 
structure. All peptides were synthesized with an N-terminal Trp to determine accurate 
concentration and one 15N-isotopically enriched Gly (15N-Gly) per peptide for NMR 
analysis (Table 1). Individual peptides and their 1:1 binary and 1:1:1 ternary mixtures 
were examined via circular dichroism (CD) and NMR. The abbreviations and melting 
temperatures (Tm) of all peptide systems examined in this study are listed in Table 1.  
2.4.1 Peptide Synthesis and Purification 
Peptides were prepared with N-terminal Trp-Gly (WG) to assist in 
spectrophotometric determination of concentration. One 15N- isotopically enriched Gly in 
each peptide chain is incorporated for NMR analysis. Sequence position of each residue 
is indicated by numeric subscripts starting from first amino acid of the leading chain. 
Therefore, N-terminal Pro of the leading, middle and lagging chains are labeled as P3, P35, 
and P67, respectively.  
All peptides were synthesized on an Advanced Chemtech Apex 396 solid phase 
peptide synthesizer using methods reported previously using 0.55 mM loading Fmoc-
Rink Amide resin.16 Briefly, 4:1 molar ratio of HATU and DIEA to amino acid coupling 
cycles were interleaved with deprotection cycles of 25% piperidine in DMF. For coupling 
of the isotopically enriched amino acid, the automated synthesis was stopped after the 
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deprotection cycle at the desired position and one equivalent of 15N-isotopically enriched 
Fmoc-Gly-OH mixed with 1 equivalent of HATU and 1.5 equivalents of DIEA. All 
residues in the Xaa position were coupled twice to prevent deletions. The N-terminal of 
all peptides except A2 was left as a free amine. A2 was acetylated using a 0.7: 0.15: 5 
volume ratio of acetic anhydride, DIEA, and DMF. A2 peptide is part of the ABC-2 helix 
designed to form a canonical collagen triple helix with a single residue offset between the 
chains. In this peptide arrangement, the electrostatically charged N-termini in case of free 
amine is placed in close vicinity inducing repulsion. It has been shown before that this 
electrostatic repulsion increases conformational disorder at the termini and decreases 
thermal stability. Additionally, the presence of free N-termini is also expected to slow 
kinetics of self-assembly. On the other hand, in our experience, tryptophan with N-
terminal acetylation significantly reduces solubility of the peptides. Therefore, in order to 
strike a balance between solubility and conformationally disordered termini, we modified 
only one peptide in the ABC-2 system to have an N-terminal acetyl group. Since ABC-1 
is designed to form a non-canonical triple helix with four residue offset, the 
electrostatically charged N-termini are placed far apart, preventing significant 
electrostatic repulsion. Therefore, acetylation of the N-terminal residues in ABC-1 was 
not required.  
The peptides were cleaved from the resin using a mixture of trifluororoacetic acid, 
triisopropylsilane, water, and 1,2-ethanedithiol in a 37.6: 0.4: 1: 1 volume ratio. The 
cleaved peptide was triturated in cold diethyl ether and centrifuged to recover the peptide 
in a pellet form. The pellet was dissolved in mili-Q water and purified in reverse phase 
HPLC on a Varian PrepStar220 with a preparative C-18 column. HPLC was carried out 
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in water with a 1% v/v gradient of acetonitrile in presence of 0.05% trifluoroacetic acid. 
The fractions collected with HPLC were then analyzed using electrospray ionization 
time-of-flight mass spectroscopy (ESI-TOFMS) on a Bruker ESI-microTOF. The HPLC 
chromatogram and mass spectra are available in Figs. 2.8 and 2.9. 
The HPLC purified peptides were rotary-evaporated to remove acetonitrile and 
lyophilized to recover a white powder that was used in preparation of CD and NMR 
samples.  
2.4.2 Preparation of Samples for CD and NMR 
All CD and NMR experiments were performed at 1 mM and 3 mM total peptide 
concentration, respectively, in presence of 10 mM TRIS buffer at pH 7.2 in absence of 
salts. In case of ABC-1, peptides A1, B and C1, their 1:1 binary mixtures A1:B, C1:B 
and A1:C1 and 1:1:1 ternary mixture A1:B:C1 were examined via CD and NMR. 
Similarly, all peptides and their combinations possible for ABC-1 and ABC-2 systems 
were also examined. Stock solution of each peptide was prepared by dissolving ~10 mg 
of lyophilized powder in 1ml of MiliQ- water. The pH of stock solutions was adjusted 
with 1M NaOH to neutral and their concentration determined spectrophotometrically on a 
Nanodrop 1000 using tryptophan molar extinction coefficient of 5502 M-1 cm-1 
monitored at 280 nm. 3 mM solution of individual peptides, their 1:1 binary or 1:1:1 
ternary mixtures were prepared by diluting the stock solutions prepared above with 
appropriate volumes of MiliQ-water and 100 mM TRIS buffer at pH 7.2 in absence of 
any salts. The prepared samples were heated to 85 °C for 5 minutes, and then left to 
incubate for 1 week at room temperature. In order to prepare samples for CD 
experiments, incubated 3mM stock solutions were diluted with 10 mM TRIS buffer at pH 
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Figure 2.7. HPLC chromatogram (left) and ESI-MS spectra of peptides A1) 
WG(POGPKG)5 monoisotopic mass[M+2H]2+, expected: 1504.8 m/z, observed: 1504.8 
m/z., A2) WG(PKGPOG)5 monoisotopic mass[M+3H]3+, expected: 1017.5 m/z, 
observed: 1017.6 m/z and B) WG(PKGEOG)5 monoisotopic mass [M+2H]2+, expected: 




Figure 2.9. HPLC chromatogram (left panel) and ESI-MS (right panel) of peptides. C1) 
WG(EOGPOG)5 monoisotopic mass [M-2H-]2-, expected: 1545.1 m/z, observed: 1545.3 
m/z, C1’) WG(EPGPPG)5 monoisotopic mass [M+2K]2+, expected: 1505.1 m/z, 
observed: 1505.4 m/z and C2) WG(POGEOG)5 monoisotopic mass [M-2H]2- , expected: 
1545.1 m/z, observed: 1545.3 m/z. 
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7.2 to obtain 1 mM peptide solutions. This sample was then left at 5 °C for 8 hours or 
overnight with the exception of the peptide combinations associated with ABC-2 which 
was incubated at 5 °C for 1 week. Longer incubation times were needed for these 
peptides to obtain high quality thermal melting transitions. After the full incubation, 45 
µL of solution was loaded into a 0.1 mm path length Hellma QS quartz cuvette and 
transferred to spectropolarimeter sample chamber for measurement.  
2.4.3 Circular Dichroism Analysis 
All CD experiments were performed on a Jasco J-810 spectropolarimeter with a 
Peltier temperature-controlled stage. For each sample, two different experiments were 
performed. First, a wavelength scan between 250 and 190 nm at a scan rate of 50 nm/min 
and a data pitch of 0.1 nm was performed to determine the secondary structure 
characteristic of species present in solution. In all cases, a maximum was observed 
between 223-226 nm. In the second experiment, a wavelength-temperature scan was 
performed in which ellipticity (θ) was monitored as a function of temperature (T) at the 
maximum observed in wavelength scan experiments. Temperature was ramped from 5 to 
85 °C at a scan rate of 10 °C/hour and a data acquisition pitch of 0.5 °C The molar 
residual ellipticity (MRE) of each samples was calculated according to the following 
equation:  
[!] = !! × ! × !" × 10 
 where θ is the observed ellipticity in millidegrees observed in thermal unfolding 
experiments, c is the total concentration of peptide in moles l-1, l is the path length in cm, 
and nr is the number of residues in the individual peptide. First derivative (dθ/dT) of the 
melting curves was calculated using a Savitzky-Golay smoothing algorithm. The 
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Figure 2.9. Thermal melting profile (A) and their first derivative curves (B) of individual 
and binary mixtures of all peptides used in this study. 
ABC-2 system are provided in figure 2.10.  
minimum observed in the dθ/dT plot is reported through the text as melting temperature, 
Tm. The melting curves and first derivative plots of peptide combinations in ABC-1and  
2.4.4 Acquisition and processing parameters in NMR spectroscopy 
The 1H,15N-HSQC, 1H,1H-TOCSY, 1H,1H- NOESY and a two dimensional 1H-1H  
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 Figure 2.10. CD wavelength scan (left panel) and thermal melting profile (right panel) 
of ABC-1 (green) and ABC-2 (red). The wavelength scans of both ABC heterotrimers 
show similar CD spectra with a positive ~ 225 nm maxima and a negative ~200 nm 
minimum characteristic of the left-handed poly-proline type II peptide conformation in 
the triple helix. A cooperative thermal unfolding is observed for both heterotrimers in the 
right panel. 
version of the three dimensional 1H,15N-NOESY-HSQC spectra of all peptide 
combinations in ABC-1 and ABC-2 system were acquired on Varian Inova Spectrometer 
operating at a 1H frequency of 500 or 600 MHz at 26 °C or 40 °C, unless otherwise 
noted. Due to significant overlap in the amide region, a three dimensional 1H,15N-
NOESY-HSQC spectra of the ABC-1 heterotrimer was acquired on a Bruker cold probe 
operating at 1H frequency of 750 MHz. In all cases, the 1H and 15N carrier frequencies 
were set to H2O resonance and 108 ppm, respectively.  
 A fast version of the 1H,15N-HSQC experiment was used to acquire two 
dimensional amide spectra with 2398 (F2) x 256 (F1) complex points in 8 scans. The 1H 
and 15N dimension acquisition windows were set to 12 and 15 ppm, respectively. 
Homonuclear 1H,1H-TOCSY spectra was acquired with 2048 (F2) x 512 (F1) complex 
points in 16 scans with a mixing time of 50 or 75 ms and a spin lock of 8000 Hz. The 
1H,1H-NOESY spectra was acquired with 2048 (F2) x 1024 (F1) complex points in 16 
scans with a mixing time of 125 ms. A 12 ppm and 10 ppm spectral window in the direct 
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and indirect dimension, respectively was used for both TOCSY and NOESY 
experiments. A two dimensional 1H,1H version of a 3D 1H,15N-NOESY-HSQC 
experiment was acquired with 2048 x 256 complex points in 256 scans with a mixing 
time of 100 and 125 ms and a spectral window of 12 (F2) x 10 (F1) ppm. The 15N 
dimension evolution time was held constant during the experiment to acquire only the 
homonuclear plane. The 3D 1H,15N-NOESY-HSQC spectrum of ABC-2 was acquired 
with 1792 (F2) x 24 (F3) x 256 (F1) complex points in 128 scans at 125 ms mixing times. 
The 1H and 15N carrier frequencies were set to water resonance and 108 ppm, 
respectively. A spectral window of 10 ppm was used for both proton dimensions and a 
spectra window of 8 ppm was used for the nitrogen dimension.  
All acquired spectra were processed using NMRPipe22 and analyzed in CcpNmr23. 
Appropriate solvent suppression filter followed by cosine-squared bell apodization was 
applied to both dimensions and the data was zero filled to the next power of two and 
Fourier transformed. Forward and backward linear predictions were used to extend the 
time domain data of the homonuclear experiments, wherever necessary. Chain specific 
sequential assignment assignments were carried out as reported previously.16  
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Chapter 3: AAB Heterotrimers to Investigate Mutations of the B Chain* 
 
3.1 Introduction 
Collagen is a triple helical structure consisting of three strands with an (Xaa-Yaa-
Gly)n repeat, and is naturally found as both a homotrimeric composition (where all three 
chains are identical) and heterotrimeric compositions (where one or two peptide chains 
are sequentially unique). Each chain is offset by one amino acid, allowing a glycine 
residue to be present in every cross section of the triple helix. Glycines fold into the 
center of the helical axis and form a stabilizing hydrogen bond with a neighboring chain, 
creating the unique triple helical fold.1,2 The offset between peptide strands introduces a 
register, or relative order (eg: ABC vs. CBA) of the strands in the folded helix. Though 
not evident in homotrimers, register becomes apparent in heterotrimers where each 
arrangement of strands results in a distinct three-dimensional surface recognized by 
receptors and other macromolecules.  
The methodology now exists to rationally create specific single composition and 
register triple helices3-5 utilitzing axial charged pairs, which create an energetic benefit 
for chains in the correct geometry.6 Many collagens, including the abundant collagen type 
I, are known to be heterotrimeric.7 With the advancement of heterotrimeric design, it is 
now possible create more realistic models of disease phenotypes. Particularly of interest 
																																																								*	The work in this chapter was published as Acevedo-Jake, A.M.; Clements, K.A.; 
Hartgerink, J.D. “Synthetic, Register-Specific, AAB Heterotrimers to Investigate Single 
Point Glycine Mutations in Osteogenesis Imperfecta” Biomacromolecules. 2016 17, 
914−921  
AAJ and KAC synthesized and purified the peptides. AAJ performed NMR experiments. 
KAC performed CD and modeling experiments. AAJ, KAC, and JDH analyzed the data 
and wrote the manuscript. 
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Figure 3.1. Sequence of A and B peptides used. Green represents the mutation site, blue 
amino acids are positively charged and red amino acids are negatively charged. Boxed 
amino acids are 15N-isotopically labeled glycines and are numbered for easy correlation 
to NMR data. 
 
is the disease Osteogenesis Imperfecta (OI), which typically results from single point 
amino acid mutations in the collagen sequence. In OI a mutation substitutes one of the 
obligate glycines for another amino acid and disrupts the folding pattern of the triple 
helix.8-10 This has significant consequences on the helical structure because these amino 
acids are larger than glycine and interrupt the canonical hydrogen bonding pattern.  
The 1CAG crystal structure was the first triple helix with an OI type mutation to 
be crystallized.11 The 1CAG structure consists of a homotrimer of (POG)5POA(POG)4 
peptides and shows significant disruption to the hydrogen bonding pattern. For example, 
four of the expected hydrogen bonds around the mutation site are replaced with water-
mediated hydrogen bonds.  This disruption widens the diameter of the triple helix to 4.5 
Å, from a normal maximum near 3 Å. Other studies have performed NMR analysis on 
this and similar homotrimeric12-15 systems as well as studies involving type IV 
collagen.16,17 For the 1CAG peptide, the crystal structure showed more hydrogen bonding 
disruption than that observed in the solution state by NMR, where the alanine in the 
leading chain participates in a hydrogen bond. Nevertheless, these structures clearly show 
the impact of glycine mutations on the triple helix. 
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Our lab previously designed a heterotrimeric sequence with an AAB guest region 
of known OI mutations.18 Multiple combinations of mutations were tested in both the A 
and B chains in order to obtain mutant helices with one, two or three glycine mutations. 
That study found that each mutation introduced had a decreasing impact on the stability 
of the helix.  The first mutation had the largest effect on the melting point of the helix, 
with each mutation thereafter having a smaller effect. While that study gave clear 
information about the melting point of the mutated triple helices, no information about 
the structure could be obtained because the system was not register or composition 
specific. 
Now that the methodologies exist to create robust single register, single 
composition heterotrimeric triple helices, here we have designed a system with 
composition and register control containing a single OI-like glycine substitution. The 
overall design is based on a previously published controlled register and composition 
AAB heterotrimer,3 shown in Figure 3.1.  This triple helix has a high melting point of 51 
°C, which allows for some of the destabilized mutated helices to fold at or above room 
temperature. Amino acids were selected to cover a wide range of naturally presented OI 
mutations including charged, branched, hydrophobic, and polar amino acids. The 
structure and composition of these systems was characterized by CD and NMR, and from 
these analyses distance constraint based models were generated to better visualize 
molecular level structural disruptions. 
3.2 Characterization of Mutant Helices 
3.2.1 Base System 
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Figure 3.2. 1H,15N-HSQC spectra of base and mutant systems. Blue traces show the B’ 
mutant peptide alone, red traces show the A peptide alone. Black shows the 2:1 AAB’ 
mixture of the peptides. Peaks labeled M represent monomer, those labeled A represent A 
homotrimer while peaks labeled G represent the AAB’ mutant labels as labeled in Fig. 1
 
To reflect the composition of type I collagen, a previously designed3 AAB single 
composition and single register system was employed as the template to model single site 
Osteogenesis Imperfecta mutations. Isotopically15N-enriched glycine was incorporated 
into the B and A chains (Figure 3.1) to verify composition of the assembled helix by 
1H,15N-HSQC spectroscopy.  
As previously observed,3 because of a high number of unsatisfied charged residues the 
B homotrimer does not fold and we record only monomeric peptide by both CD and 
NMR. The A peptide, however, can fold into a homotrimer (three peaks of equivalent 
volume by 1H,15N-HSQC) with a melting temperature of 32 °C. The 2:1 mixture of the A 
and B peptides results exclusively in a single register and single composition AAB 
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Figure 3.3. NOESY HSQC of the AAB base peptide. 
 
heterotrimer. This system displays a characteristic helical signal by CD spectroscopy with 
a maximum around 225 nm and a minimum at 190 nm, and has a high melting 
temperature of 51 °C. By NMR, four peaks (G1, G2, G3 and G4) of equal volume in the 
1H,15N-HSQC spectra confirm AAB composition (Figure 3.2). Comparison of the folded 
AAB peak volume to the monomeric peptides (M1 and M2) reveals the equilibrium 
population of base trimer is high in comparison to the mutant systems (Table 3.1). 
Additionally, measurement of T1 and T2 relaxation values for the isotopic labels was 
performed. In agreement with previous reports, the monomeric single peptide strands are 
characterized by a low R2/R1 ratio (around 2.00 or below), while the folded helical peaks 
show significantly higher R2/R1 ratios (Table 3.3). Finally these 15N-glycine labels were  
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Alpha homotrimer peak T1 T2 
A1 0.4590.031 0.0320.008 
A2 0.5220.042 0.0500.009 
A3 0.3990.041 0.0600.011 
Table 3.1. Alpha homotrimer relaxation values. 
 
Peak Base B-Ala B-Ser 
G1 14.85 20.76 15.72 
G2 9.55 10.67 13.53 
G3 21.32 13.79 18.63 
G4 8.00 10.02 17.84 
Table 3.2. Peak volumes from 1H, 15N-HSQC 
 
used to probe the surrounding helical topology by 1H,15N-NOESY-HSQC. The NOEs 
determined for each label (Appendix 1) were used to generate a model of the base 
heterotrimer. These data characterize the base AAB single register single composition 
system, and are used as a reference of comparison to the mutant systems. 
3.2.2 Mutant Systems 
For simplicity, AAB heterotrimeric helices with a glycine substitution in the B 
chain are named after the amino acid which replaces glycine, for example B-Ala or B-
Ser. The A chain is identical in all cases. With the single mutation in the helix, our series 
shows increasing disorder associated with the character of amino acid (Ala > Ser > Val > 
Asp > Arg) which, with the exception of arginine, closely resembles the trend shown the 
clinical cases8,24 and previous reports.25 The mutations are ordered using a combination 
of the melting points from CD and the composition information from NMR experiments. 
Unlike previous reports however, we are able to report structural as well as compositional 
disruptions to the initial base system. Additionally, in the case of B-Ala and B-Ser, we 




Substitution Name AAB’ 
Tm 





Rel. Vol.  
Glycine BASE 51 °C Single composition, 
single register AAB 
14.85, 9.55, 
21.32, 8.00 
0.33 0.67 - 
Alanine B-Ala 30.5 °C Single composition, 
single register AAB’ 
20.76, 10.67, 
13.79, 10.02 
0.44 0.56 - 




0.61 0.37 0.02 
Valine B-Val - Multiple compositions 10.28, 9.62, 
7.84, 4.71 
0.63 0.21 0.16 
Aspartate B-Asp - Partially Folded 7.10, 5.24, 2.11, 
8.35 
0.75 0.07 0.18 
Arginine B-Arg - Only homotrimers - 0.74 - 0.26 
Table 3.3. Summary of experimental properties of the sequences. Melting points are 
from Circular Dichroism. Relaxation values are from 15N relaxation experiments on the 
heterotrimeric solutions in numerical order of the label. Peak volumes are from the 
1H,15N-HSQC spectra of the mixed heterotrimeric solutions. A more detailed description 
of the assignment process, additional relaxation values, and TOCSY are given in 
Appendix 2. 
Of all the B chain mutations investigated, only the B-Ala system displays perfect 
composition and register control, on the basis of the single transition in CD combined 
with the single triple helical population in NMR studies. The CD melting spectra of this 
sample shows a single strong cooperative transition again suggesting this AAB’ mutant 
heterotrimer folded (Figure 3.4) because there are no other species present by NMR. 
 Specifically, the 1H,15N-HSQC of the B-Ala reveals an AAB’ heterotrimer 
similar to the base, with four peaks of roughly equal ratio (G1, G2, G3 and G4) and high 
R2/R1 ratios (Figure 3.2, Table 3.3). Comparison of equilibrium peak volumes of the 
folded versus unfolded peptides reveals the B-Ala AAB’ population is only slightly lower 
than the base system (base is 0.33:0.67 monomer to trimer versus 0.44:0.56 in B-Ala), 
suggesting the energetic penalty of this mutation is quite mild. High relaxation values for 
the B-Ala mutant reveals that the labeled 15N-glycines surrounding the mutation site are 
folded and well-ordered (Table 3.3). Because these values are more characteristic of 
organized helical rather than unfolded monomeric peptide, the structural disruptions to 
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Figure 3.4. First derivative of Circular Dichroism melting experiments demonstrating the 
relative thermal stabilities of the compared systems. For easy comparison, the component 
peptides AAA and BBB and their combined AAB triple helix are shown in all graphs in 
red, blue and green respectively. Modified peptides with substitutions away from Glycine 
are shown in black. 	
the helical topology must be quite localized. This differs from some previous reports 
employing homotrimers, which report that the triple helix is not able to re-nucleate past 
the mutation site and the terminal regions remain unfolded.26 Finally, because each of the 
labeled residues in the AAB’ mutant lie at unique 1H ppm values, it was possible to 
determine NOE correlations to surrounding protons for each isotopic label. These 
correlations (Appendix 1) were used to generate a model of the topology surrounding 




The incorporation of a serine mutation into our sequence still allows triple helical 
folding, though we observe additional compositional disruptions. For the B-Ser system 
the AAA homotrimer and the AAB’ heterotrimer are both observed by NMR to fold, but 
the AAA population is low when compared to the equilibrium population of mutant 
heterotrimer and monomer (0.02 : 0.37 : 0.61; homotrimer : heterotrimer : monomer). 
Overall, this results in less A chain available for heterotrimer folding, and reduces the 
total amount of folded AAB’ helix present. In addition, the equilibrium ratio between 
folded and unfolded peptides is relatively lower than for the AAB base (Table 3.3). 
Relaxation values, as for the B-Ala mutation, confirm both that the triple helix re-
nucleates on both sides of the mutation and that these regions are well-ordered 
The remaining mutants, Val, Asp, and Arg show more significant compositional 
disruptions with larger relative amounts of homotrimer. Additionally, dynamic values of 
the mutant heterotrimers suggest more significant structural disruptions and decreased 
helical organization. In these cases, the system accommodated the mutation by 
minimizing the amount of folded mutant AAB’ helix, shifting the equilibrium toward the 
AAA homotrimer. For these systems, signal overlap prevented unambiguous assignment 
of neighboring NOEs and helical register. 
3.2.2.3 Valine 
The valine mutation results in folding of the intended mutant heterotrimer in 
addition to a significant population of the A homotrimer. The CD melting profile shows a 
broader transition representing this mixed population (Figure 3.4). By NMR, the four 
1H,15N-HSQC peaks for the mutant have equal volumes and represent the AAB’ 
composition. Similar to the B-Ala and B-Ser systems, the relaxation values confirm that 
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Table 3.4. Comparison of lost and gained interactions. Lost hydrogen bonds are 
backbone hydrogen bonds that would be expected to take place in the Base structure, but 
no longer are formed in the same way. Compensating interactions are any interactions 
that are not present in the Base structure. 
the helix refolds around the mutation site.  Three of these peaks, G1, G2, and G3, have 
high R2/R1 ratios comparable to the base and must be well-ordered. The fourth peak, G4, 
has a lower R2/R1 ratio; though we still classify it as helical, this site is somewhat less 
organized than the others. This suggests that in the case of valine mutants the structural 
disruptions are less localized and propagate further along the helical backbone. The triple 
helix - monomer equilibrium is comparable to B-Ser system (Table 3.3), and slightly less 
favorable than for the base population. Unlike B-Ser however, the B-Val AAB’ helix and 
the base AAA homotrimer populations are present in equal amounts (Table 3.3). 
Unfortunately for the B-Val system, signal overlap in the 1H dimension prevented 
unambiguous NOE assignments to be made and therefore a model was not generated. 
 
3.2.2.4 Aspartate 
With the B-Asp mutation, the total equilibrium population of folded helices 
(homotrimers and heterotrimers) is low in comparison to the B-Ala, B-Ser, and B-Val 
systems  (Table 3.3). Because the population of heterotrimers is so low, by CD only the 
strong AAA homotrimer transition is observed. However, by 1H,15N-HSQC it is possible 
to clearly distinguish both the B-Asp heterotrimer and the AAA base homotrimer. For 




Interactions Peak diameter of helix 
B-Ala 5 3 8 4.7 Å 
B-Ser 2 4 6 3.7 Å 
1CAG 11 4 N/A 6 4.2 Å 
T1-898(G109S) 12 4 N/A N/A ~5 Å 
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this B-Asp system however, the homotrimer peak volume is four times greater than B-
Asp helix peak volume, corroborating the phenotypic severity reported from previous 
studies associated with aspartate mutations.25 The four AAB’ 1H,15N-HSQC peaks, G1, 
G2, G3 and G4, show equal volumes; for three of these peaks, G1, G2, and G4,  the 
R2/R1 values classify them as ordered triple helix. The fourth heterotrimer peak, G3, has 
a lower R2/R1 value and is not well-ordered. This relaxation data reveals that, like the 
valine mutant, the helical backbone surrounding the aspartate mutation is less well-
organized than the B-Ala and B-Ser systems. 
3.2.2.5 Arginine 
Previous studies of OI mutations have shown that charged and branched amino 
acid mutations result in the harshest patient phenotypes and largest disruptions to the 
helical structure.8,9,25 Consistent with these reports, characterization of the B-Arg system 
shows the most perturbed composition of all the prepared mutants. The AAA base 
homotrimer, in addition to the monomers for both the A and B’ chains are apparent in 
NMR (Figure 3.2). For this system there were no definitively assignable populations of 
AAB’ heterotrimer. The presence of the new and large monomeric peak, M4, suggests a 
partially folded intermediate. The considerable steric and conformational consequences 
of incorporating arginine into the B chain apparently prevents heterotrimer formation, 
and instead the equilibrium favors the monomer state and AAA homotrimer.  
3.3 Structural Disruptions around Mutation Site 
Both the alanine and serine mutant systems displayed well-folded AAB’ 
heterotrimeric populations, where the register and composition was clear and 









Figure 3.6. a.) Ramachandran plot of B-Ala helix compared to Base b.) Chart of 
interactions lost and gained in B-Ala model. R1 represents lysine side chain, R2 represents 
glutamate side chain, and R3 represents aspartate side chain. Blue interactions are 
expected backbone hydrogen bonds that formed, green are expected axial charge pairs 
that are formed, red are broken hydrogen bonds or charge pairs, and purple are new 
compensating interactions c) Generated model of B-Ala. Alanine is shown in yellow. 
ppm values, it was possible to determine NOE correlations of neighboring protons 
for each isotopic label. From these 1H,15N-NOESY-HSQC (Figure 3.5)spectra restraints 
were generated and used to guide modeling by Rosetta (constraints available in Appendix 
1).  
In these models it is apparent that B-Ala compensates for the mutation by a 
moderate loosening of triple helical topology (Figure 3.6). The helix has a small area of 
relaxed folding immediately surrounding the mutation site to accommodate the additional 
methyl group. This results in significant splaying away from the central triple helical 
axis, which peaks at the mutation site (Figure 3.8). Alterations to the dihedral angles of 
the peptides prevent three axial charge pairs from forming adjacent to the mutation site, 
but also enable the helix to quickly re-nucleate and keep the disorder localized. In  
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Figure 3.7. a.) Ramachandran plot of B-Ser helix compared to base b.) Chart of 
interactions lost and gained in B-Ser model. R1 represents lysine side chain, R2 represents 
glutamate side chain, and R3 represents aspartate side chain. Blue interactions are 
expected backbone hydrogen bonds that formed, green are expected axial charge pairs 
that formed, red are broken hydrogen bonds or charge pairs, and purple are compensating 
interactions that formed. * denotes an interaction far from labeling site that is most likely 
a product of termini affects, not the mutation. c) Model of B-Ser. Serine shown in yellow 
 
addition to the unsatisfied charge pairs, five interchain hydrogen bonds are lost. To offset 
these lost interactions, the model suggests that eight new hydrogen bonds form. Three 
involve hydroxyproline side chains, two involve charged side chains, and the last two are 
between backbone atoms. Despite the compensating interactions, the mutant structure is 
less stable as indicated by CD and less well-ordered as indicated by loss of key NOE 
correlations, and the decrease in 15N-relaxation values. 
In spite of being a larger amino acid, B-Ser has fewer interruptions to the 
backbone hydrogen-bonding network than the alanine mutation, though the dihedral 
angles of residues surrounding the mutation site deviate to a greater extent than the B-Ala 
model (Figure 3.7). These altered angles allow the triple helix to compensate for the 
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disruption, and reduce the local unfolding. This difference from the B-Ala model could in 
part be attributed to the polar nature of the serine side chain, which could allow for polar 
interaction with the backbone of other chains, or other amino acid side chains. These 
interactions are seen in a homotrimeric system12 and theoretical models.27,28 The polar 
group on the mutated amino acid enables the side chain to remain alongside the helix 
rather than away and allows most normal backbone hydrogen bonds to form. Specifically, 
the B-Ser triple helix loses four backbone hydrogen bonds, and four stabilizing axial 
charge pairs. To counterbalance these lost interactions, the model suggests six additional 
non-canonical hydrogen bonds may form (Figure 3.7, Table 3.4). These new hydrogen 
bonds are all interchain and present in two distinct types: hydroxyproline OH mediated 
hydrogen bonds (four) and new backbone hydrogen bonds (two). However, the additional 
serine polar side chain interactions allow the helix to fold into a closer approximation of 
the base helix where the radius only deviates to 3.7 Å instead of almost 5 Å as in the B-
Ala case (Figure 3.8).  
3.4 Comparisons to Other OI Models 
When compared to prior studies of OI-type mutations, our results suggest these 
disruptions have limited additive effect. Though prior homotrimeric systems include 
three mutant strands rather than a single mutant chain, they do not observe significantly 
increased destabilization due to the triple mutation.11 Similar to prior reports we observe 
the relative impact of the amino acids range from the smallest amino acids alanine and 
serine, which are seen to disrupt the triple helix the least, followed by the larger branched 
or charged amino acids valine, asparate and arginine which more dramatically disrupt 
folding. However, the degree of structural disruption per mutations was quite different 
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between this study and the previous literature where here we observe similar disruption 
for a single substitution as compared to triple-substituted homotrimers. For example, in 
published homotrimeric cases there are similar disruptions to the hydrogen-bonding 
pattern when compared to this study with only one mutated amino acid.11 This further 
suggests that the disruption of these OI-type mutations is not an additive effect. 
Figure 3.8. Triple Helical Radius of the mutated, base, and 1CAG helices 
Additionally, our charge-rich heterotrimer allows our systems to fully re-nucleate 
past the mutation site, allowing visualization of how natural systems may accommodate 
these local disruptions. Furthermore, homotrimeric models will not be able to account for 
all factors influencing OI phenotypes like heterotrimeric mimics, including the 
presentation of mutants in collagen-binding motifs and the influence of neighboring 
amino acids from both chains. 
Osteogenesis Imperfecta mutations follow a clear pattern based upon the size, 
charge, and hydrophobicity of the substituted residue. These patterns are replicated in our 
experiments. The models created here are the first collagen mimetic peptides that fold 
into the correct composition with an OI-type mutation. Each mutation has a different way 
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of compensating for the steric effects of the substitution. B-Ala flips the side chain of 
alanine out of the helix; B-Ser compensates by having a few amino acids with extreme 
dihedral angles to maintain the hydrogen bonds. From our experiments, all the mutations 
have an asymmetric effect on the folding of the triple helix, with the greatest disruption 
on the N-terminal side of the Gly substitution. While these systems compensate with 
structural disruptions, B-Val, B-Asp, and B-Arg compensate by not forming the intended 
structure, instead excluding the mutated B-chain and forming the AAA homotrimer.  
3.5 Conclusions 
Our system illustrates the possibilities for systems to self-assemble into the 
correct composition and register while still having highly disrupted local structures. This 
reinforces the robustness of the design principles, and the flexibility of the axial charge 
pair in heterotrimer collagen mimetic peptide design. These systems are limited, 
however, by the equilibrium conditions at which the heterotrimer folds. If the energetic 
benefit of triple helical folding is not high enough the ratio between the monomer and 
folded state can be unfavorable, especially in cases where the designed sequence 
incorporates severely destabilizing mutations. 
These interactions can be used to design a wide variety of disease models or 
models of the active binding sites in collagens. On-going investigations are working to 
incorporate natural guest sequences surrounding a mutation into similar register-specific 
AAB-type triple helices. These systems will more closely mimic clinical phenotypes and 
can also examine the effect of rigidity vs. flexibility of the guest region, which may 
exacerbate or mitigate the disruption of the mutation.29,30 Several binding sites, including 




Figure 3.9. a) ESI-TOF MS of the purified fractions (Predicted MW [M+H]+ =3210.55 
Observed =3211.48) and b) HPLC trace of the Base A peptide. c) ESI-TOF MS of the 
purified fractions (Predicted MW [M+H]+ =3062.23 Observed =3061.60)  and d) HPLC 
trace of the Base B peptide. e) ESI-TOF MS of the purified fractions (Predicted MW 





Figure 3.10. a) ESI-TOF MS of the purified fractions (Predicted MW [M+H]+ =3095.23 
Observed =3094.48) and b) HPLC trace of the B-Ser B peptide. c) ESI-TOF MS of the 
purified fractions (Predicted MW [M+H]+ =3107.12 Observed =3108.11) and d) HPLC 
trace of the crude B-Val B peptide. e) ESI-TOF MS of the purified fractions (Predicted 




Figure 3.11. a) ESI-TOF MS of the purified fractions (Predicted MW [M+H]+ =3164.10 
Observed =3164.30) and b) HPLC trace of the crude B-Arg B peptide. 
binding and regulation. In future investigations, incorporation of natural type I 
collagen guest sequences could be incorporated to better examine how these mutations 
affect the presented face of the active site and disrupt binding and local structure. 
3.6 Experimental 
3.6.1 Peptide Synthesis 
Peptides were prepared using standard solid phase synthesis utilizing Fmoc-
protected amino acids. The solid phase support was a low loading (0.37 mmol/gram) 
Rink amide MBHA resin to give the C-terminally amidated product. A 25% by volume 
piperidine solution in dimethylformamide (DMF) was used for Fmoc-deprotection cycles, 
and coupling cycles were performed with 2-(1H-7-Azabenzotriazol-1-yl)-1,1,3,3-
tetramethyl uronium hexafluorophosphate methanaminium (HATU) and 
diisopropylethylamine (DiEA). For cycles that incorporated an 15N isotopic label, 
reagents were combined in the ratio 1:2:2:3 (resin: amino acid: HATU: DiEA); for all 
other cycles the ratio used was 1:4:4:6. Acetylation at the N-terminus was completed with 
a 1:8:4 mixture of resin: acetic anhydride: DiEA in dichloromethane; this step was 
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performed twice. Cleavage from the resin was performed for three hours using 1,2-
ethanedithiol: H2O: triisopropysilane (1:1:0.4) in 20 mL trifluoroacetic acid (TFA). The 
reaction mixture was then drained and the TFA removed by rotary evaporation under 
reduced pressure. When less than 5 mL solution remained, ice-cold diethyl ether was 
used to precipitate out the crude peptide. The peptide was centrifuged to obtain a pellet; 
this step was repeated two times using 100 mL of diethyl ether to further remove TFA. 
3.6.2 Peptide Purification 
After drying overnight the crude peptides were dissolved in deionized water and 
purified by reverse phase high-pressure liquid chromatography (HPLC). Peptide 
molecular weights were confirmed with electrospray ionization time of flight mass 
spectrometry (ESI TOF-MS) (Figures 3.9-11) and lyophilized to give the purified peptide
3.6.3 Sample Preparation 
The lyophilized powders were dissolved in autoclaved deionized water to prepare 
stock solutions. From these solutions NMR samples were prepared by dilution to a final 
concentration of 3 mM in 9:1 H2O:D2O in a 10 mM PO4 buffer. Circular dichroism (CD) 
samples were prepared to a final concentration of 0.3 mM. All samples were annealed for 
15 minutes above 80 °C, allowed to cool to room temperature and equilibrated for 1 week 
at room temperature, followed by 1 week incubation at 4 °C. CD wavelength and melting 
spectra were used to confirm peptide folding for each sample before NMR samples were 
measured.   
3.6.4 NMR Spectroscopy 
All TOCSY, and 1H,15N-HSQC and 1H,15N-NOESY-HSQC experiments were 
performed on a Varian spectrometer of 800 MHz containing a cryogenic probe. The 
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nitrogen carrier frequency was set at 110 ppm, while the proton carrier frequency set to 
the water signal. All experiments were performed at 10 °C. Chemical shift assignments of 
residues were made using TOCSY spectra. For TOSCY spectra 1120 x 512 complex 
points and 128 scans were acquired; the mixing time was 85 ms and sweep width 12 kHz 
in both dimensions. The 1H,15N-HSQC were collected with 1040 x 256 complex points 
for a total of 16 scans. A sweep width of 10 kHz in the proton and 2432 Hz in the 
nitrogen dimension was used. To compare relative peak volumes of folded and unfolded 
states, for each 1H,15N-HSQC of an AAB’ heterotrimer the total peak volume was set to 
1. Because of the difference in the relaxation rate of the monomer and folded helix no 
quantitative relationship between the populations can be determined from this ratio, but a 
general comparison between the mutation types may be made. A 2D version of the 3D 
1H,15N-NOESY-HSQC was collected with 100 ms mixing time, 64 scans, 1200 x 256 
complex points; the spectral window was 12 kHz in the direct dimension and 12 kHz for 
the indirect dimension. 15N relaxation experiments were performed on 3 mM samples as 
previously described on a 500 MHz Varian spectrometer.26 Data was processed and 
analyzed using NMRdraw, and ccpnmr processing suites.27, 28  
3.6.5 CD Spectroscopy 
Circular dichroism (CD) experiments were collected on a Jasco J-810 
spectropolarimeter equipped with a Peltier temperature controller. Ellipticity 
measurements were performed between 190 and 250 nm to characterize helical secondary 
structure of the samples. The maximum wavelength recorded in this region was then 
selected to be monitored between 5 and 85 °C at a heating rate of 10 °C/hour. The first 
derivative of this experiment was calculated using a Savitzky-Golay smoothing 
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algorithm, and the melting temperature was assigned to the minimum(s) detected. The 
molar residue ellipticity (MRE) value was calculated with the following equation, where 
Ɵ represents the experimental ellipticity in millidegrees, m is the molecular weight of the 
triple helix (g/mol), c is the peptide concentration (milligrams/milliliter), l is the 
pathlength of the cuvette (cm), and nr represents the total number of residues in the triple 
helical system.  
[!] = !! × ! × !" × 10 
3.6.6 Molecular Modeling 
From NMR studies, specifically 1H,15N-NOESY-HSQC, constraints were created 
for the folded heterotrimers (available Appendix 1). Negative constraints were also 
created for correlations that existed in the base structure, but not the mutated structure. 
Positive constraints were set from 0-4 Å, and negative from 6-10 Å. These constraints 
were utilized in the Rosetta Relax application29,30 to generate a set of structures. 
Generated structures were assessed for compliance to the constraints. For all positive 
correlations the distances are below 5 Å, and above 5 Å for negative constraints. Samples 
were run iteratively with the best structure from the previous run used with changes to the 
standard deviation until a compliant structure was found. For constraints that were hard to 
satisfy, the standard deviation was decreased to increase the energetic penalty for longer 
deviations. The structure with the best compliance to NMR data was selected. 
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A collagen triple helix is a supramolecular complex that consists of three peptide 
chains in the polyproline II conformation1, 2 that self-assemble to create a right-handed 
superhelix. Each chain has a three amino acid repeat of Xaa-Yaa-Gly with stabilizing 
hydrogen bonds that form between a glycine NH and the backbone carbonyl of an Xaa 
position in an adjacent chain. In a triple helix the separate peptide strands may be the 
same or different sequences which determines the composition of the triple helix. When 
all three peptides are identical the helix is called an AAA homotrimer, when there are two 
unique peptides the helix is an AAB heterotrimer and when all three are distinct the helix 
is called an ABC heterotrimer. Because there is a one amino acid offset between each 
chain of the triple helix, the order of the peptides can create unique triple helical registers 
in heterotrimers. For example, an AAB triple helix will be distinct from an ABA because 
different chains will be in the leading, middle, and lagging positions.  
The design of composition and register specific collagen triple helices has 
advanced allowing for more complex models of disease conditions, specifically the 
mutations found in Osteogenesis Imperfecta (OI).3 OI is a disease that usually results 
from mutations of glycines in the Xaa-Yaa-Gly repeat in type I collagen. These mutations 
cause a wide range of disease phenotypes based upon the identity of the amino acid 
                                                
* The work in this chapter was published as Clements, K.A.; Acevedo-Jake, A.M.; 
Walker, D. R.; Hartgerink, J.D. “Glycine Substitutions in Collagen Heterotrimers Alter 
Triple Helical Assembly” Biomacromolecules. 2017, 18, 617-624. 
AAJ and KAC synthesized and purified the peptides. AAJ performed NMR experiments. 
KAC performed CD and modeling experiments. DRW did helical twist analysis. DRW, 
AAJ, KAC, and JDH analyzed the data and wrote the manuscript. 
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replacing glycine and the location of the mutation in the sequence.4, 5 From clinical data, 
experiments, and theoretical models the severity of the disease has been correlated with 
the size and charge of the substituted amino acid, specifically Ala < Ser < Cys < Arg < 
Glu < Asp < Val in order from least to most disruptive.4, 6-8 The placement of the mutation 
in the A chain or B chain also changes the severity because, in principle, two mutations 
are incorporated when the A chain is mutated, and only one when the B chain is 
mutated.4, 5 
Before register and composition control were available, the first OI models were 
homotrimers. Though these systems gave significant insight into glycine mutations in 
collagen, they cannot accurately account for structural and thermal disruptions found in 
natural heterotrimeric mutations. For a glycine to alanine substitution in a homotrimer the 
mutation is always incorporated into all three chains of the triple helix.9 Amongst other 
changes to the helix structure, this has been shown to result in the loss of four 
intermolecular backbone hydrogen bonds. This local disruption decreases the melting 
temperature, Tm, of the helix by 29 °C compared to the base (POG)10 sequence. Further 
mutations have been incorporated into a homotrimeric triple helix and studied with 
circular dichroism and NMR.9-11 In homotrimers generally, a mutation typically results in 
the loss of three to four backbone hydrogen bonds and a sharp decrease in thermal 
stability. With the development of ABC heterotrimeric triple helices with compositional 
control, mutations could selectively be made in just one or two chains. Previously, our 
lab prepared an ABC triple helix with a central AAB guest region to model mutations in 
one, two and all three chains.12 We saw that once the triple helix was mutated, successive 
mutations had a smaller impact on the stability of the helix; specifically the 
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destabilization was not linear with respect to the number of mutations. However, this 
system gave no information about composition or register, and also lacked structural 
characterization of the mutation site. 
Recently, utilizing a robust design of an AAB register and composition controlled 
triple helix, just the B chain of the triple helix was mutated to study the impact on the 
triple helix stability and structure.13 This system showed a clear correlation between the 
structural disruption and the size or charge of the substituted amino acid. Smaller 
uncharged amino acids exhibited less disruption to the triple helix than large charged 
amino acids. The mutations also showed an impact on the composition and register, 
where increasing size or charge of the mutated amino acid led to disruptions away from 
the desired AAB’ population. Here we complement that study by analyzing the impact of 
mutations to the A chain of AAB heterotrimers. We also examine systems in which both 
the A and B chains have been mutated. Our analysis shows the strong driving force for 
triple helices to avoid double mutations and the changes in helical composition that arise 
to accomplish this despite the loss of many stabilizing charge-pair interactions. 
4.1.1 Peptide Design 
To mimic natural OI disruptions, we used a highly stable AAB register controlled 
system as our base sequence and introduced glycine mutations.14 In order to explore the 
molecular structure of the triple helices, 15N isotopically labeled glycines are placed 
around the mutated region and also were placed N-terminally (Fig. 4.1) to give 
information on refolding. Additionally two different amino acid substitutions (alanine or 




Figure 4.1. Sequences, compositions and registers of peptides used. Red amino acids are 
negatively charged, blue are positively charged. The yellow boxed glycines are 15N 
isotopically labeled. A is the B-Ala mutant, B is A-Ala mutant which is observed to form, 
C is A-Ala mutant which was intended but is not observed to fold, D is the 3-Ala mutant. 
The serine mutants are identical other than the substitution of alanine for serine.
 
A-Ser depending on the amino acid substituted. The double mutant systems are called 3-
Ala and 3-Ser. 
4.2 Characterization of Mutant Triple Helices 
4.2.1 Base AAB Triple Helix 
To improve upon the physiological relevance of OI models and gain better insight 
into natural systems, a previously designed register and composition controlled AAB 
heterotrimer was used to mimic the composition of type I collagen.14 To ease composition 
verification in our systems a single 15N-glycine label is included in the A chain and two 
15N-glycine labels in the B chain. This produces four folded 1H,15N-HSQC peaks in an 
AAB triple helix as well as a peaks each for the cis and trans conformations of the labels 
in unfolded single A or B chains.13 This is a well-folded system, shown by the high ratio 
of trimers to monomers, and the relatively high ( > 8) relaxation values of the 1H,15N-















Glycine14 Base 51.0 °C Single composition, 
single register AAB 
14.9, 9.6, 21.3, 
8.0 
0.33 0.67 - 
Alanine13 B-Ala 30.5 °C Single composition, 
single register AAB’ 
20.8, 10.7, 13.8, 
10.0 
0.44 0.56 - 
Serine13 B-Ser 29.5 °C AAB’ folded as well as 
AAA homotrimer 
15.7, 13.5, 18.6, 
17.8 
0.61 0.37 - 
Alanine A-Ala 34.0 °C Single composition, 
single register A’BB 
7.7, 8.9, 11.9, 
7.8, 6.0 
0.50 - 0.50 
Serine A-Ser 30.0 °C Single composition, 
single register A’BB 
8.6, 11.1, 6.7, 
10.4, 9.4 
0.82 - 0.18 
Alanine 3-Ala 19.0 °C Single composition 
A’A’B’ 
5.3, 2.4, 3.0, 4.5 0.81 0.19 - 
Serine 3-Ser 18.0 °C Single composition, 
single register A’A’B’ 
8.3, 4.9, 5.3, 5.8 0.83 0.17 - 
Table 4.1. NMR Experimental Results of the different Osteogenesis Imperfecta model 
systems. Heterotrimer Tm is the melting point of the folded heterotrimer by CD. The 
R2/R1 value, or relaxation value, is for each isotopic label (G1-G5) in the order from 
leading to lagging chain. Relative volumes are the relative volume of the peaks when the 
total peak volume is set to 1 (see experimental procedures for more details).
indicate monomeric peptides while higher values indicate increased local rigidity of a 
folded helix. The CD melting spectra corroborates the robustness of the base heterotrimer 
showing a single transition at 51 °C. The helical twist of the base triple helix has a typical 
amount of variation and falls mostly within the range of a typical POG triple helix. It 
does have one point outside of the range, which is believed to be the result of strain 
induced by the surrounding charge pairs.  
4.2.2 A-Chain Mutants 
Like the base triple helix, the triple helices A-Ala and A-Ser are mixed at a 2:1 
ratio of A’:B and are designed to fold into an A’A’B triple helix (A’ indicates the 
mutated version of the A peptide) composition and register. As seen for the base triple 
helix, this composition should yield four peaks in the trimer region of the 1H,15N-HSQC 
spectrum corresponding to the four different isotopic labels in the trimer (Figs. 4.1-2). 
Instead however, the NMR showed five distinct trimer signals of equal volume for both 
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Figure 4.2. 1H,15N-HSQC of the peptide systems. Black spectra are the AAB mixture. 
Blue is only the B strand used in the system. Red is only the A strand used in the system.  
G1-G5 denote the heterotrimer present and are labeled in the same order as shown in 
Figure 1. A1-A3 denote the AAA homotrimers. M1-M3 denote the peptide monomers. B-
Ala and B-Ser spectra are reproduced from reference 13 for comparison. 
the A-Ala and A-Ser cases, labeled G1-G5 in Fig. 4.2. In our labeling scheme, these five 
peaks can only appear if the composition has been altered from the intended A’A’B 
composition to an A’BB composition. One peak represents the label in the A’ chain, and 
the B chains each contain two 15N labels. (Fig. 4.2). While type I collagen is quite long 
(~1000 residues) our shorter 30-mers are not able to compensate for the local disruption 
that would be induced by two glycine mutations in the A chain, and instead preferentially 
form the A’BB composition. Our results suggest that the energetic barrier needed to 
compensate for two A chain mutants outweighs the stabilization that the A’A’B system 
could produce by folding; in this manner natural systems may also be affected and suffer 
from poor folding equilibria. 
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Figure 4.3. Circular Dichroism. First derivatives of the melting plots are shown for 
clarity. The melting temperature is defined as the minimum of the curve. The Base AAA 
peptide is shown in all three panels because it is a competing homotrimer in the solution.
 
A-Ala melted at 34 °C, making it less stable than the base Tm of 51 °C, but more 
stable than a previously reported B-Ala triple helix which melted at 30.5 °C (Table 4.1, 
Fig. 4.3). Both A-Ala and B-Ala have disrupted equilibria, as seen by the higher ratio of 
monomer to heterotrimer than in the base system. However, the A-Ala A’BB helix that 
folds has five highly stabilizing charge pairs while the B-Ala AAB’ helix has seven that 
form (Table 4.2). The increase in melting point is in contrast with the relaxation values 
(R2/R1) for the isotopic labels (7.7, 8.9, 11.9, 7.8, and 6.0) (relaxation values are in order 
from leading to lagging chain) which are also lower than both the base system and B-Ala, 
indicating A-Ala is a less ordered helix and is likely to have a more disordered 
conformation around the mutation (Table 4.1). Commonly, relaxation values are 
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used to measure the quality of triple helical folding, and it is intuitive to assume that a 
well-folded helix would have a higher melting point than one with lower relaxation 
values. However, we see the opposite, where our less well-folded helix A-Ala has a 
higher melting point than our better-folded helix, B-Ala. This suggests that the melting 
point is not comprehensive in accessing the quality of a triple helix, and other methods 
such as NMR and molecular modeling must be used. 
A model was created of the A-Ala A’BB heterotrimer utilizing constraints from 
NMR (Fig. 4.4). When compared the B-Ala AAB’ model, the A-Ala A’BB model has 
four more formed backbone hydrogen bonds, but two less formed axial charge pairs as 
shown in Fig. 4.5 and Table 4.2. This again is surprising because, the more disordered 
helix, according to the relaxation values, has more backbone hydrogen bonds formed. 
However, looking at the helical twist of the mutated triple helices gives additional insight 
to this issue. The helical twist is the angle (in degrees) that the triple helix rotates from 
one cross section to the next (see supporting information and experimental procedures for 
a detailed description). For a general (POG)10  triple helix the helical twist varies between 
approximately 95-115 ° from one cross-section to the next. In the B-Ala case (Fig. 4.7) 
the helical twist varies more dramatically with values from 70 to 130 ° with many swings 
from smaller to much larger angles. This shows a helix with a tightly twisted cross-
sections (larger angle) adjacent to loosely twisted (smaller angle) cross-sections. 
However, while the A-Ala case has variation, it is primarily to a larger angles near the 
mutation site. We propose that the tightly twisted region around the mutation site allows 
the triple helix to compensate for the steric effects of the mutation, while the B-Ala case 
















B-Ala13 5 3 8 7 
B-Ser13 2 4 6 6 
A-Ala 1 0 0 5 
A-Ser 1 0 5 5 
3-Ala 1 1 3 9 
3-Ser 2 1 7 9 
Table 4.2. Results of the modeling experiments. Lost hydrogen bonds are backbone 
hydrogen bonds that are expected to be found in the model, but are not present. Lost 
charge pairs are designed axial charge pairs that are not formed in the model. 
Compensating interactions are hydrogen bonds that are not present in the base structure, 
but are formed in the model. Formed charge pairs are designed axial charge pairs that are 
present in the model. 
in helical twist, resulting in a triple helix with more interactions, but which is more 
constrained and relatively inflexible.  These systems show the demands of charge pair 
formation to the triple helix, as well as the flexibility needed to compensate for a glycine 
mutation. 
A-Ser melted at 30 °C, similar to the B-Ser triple helix that melted at 29.5 °C, and 
B-Ala at 30.5 °C. The similar melting point is surprising because in the models B-Ala 
and B-Ser have formed seven and six highly stabilizing charge pairs, respectively, while 
B-Ser has only formed five. The relaxation values of the 1H,15N-HSQC peaks the in the 
A-Ser spectrum were  similar to the A-Ala cases, suggesting a moderately disordered 
helix. These relaxation values are lower than the B-Ala and B-Ser, suggesting a less 
ordered helix with a similar melting point. When comparing the A-Ser and A-Ala spectra, 
much less A-Ser was seen to fold by NMR with a relative volume of 0.18 trimer, 
suggesting this mutation affects not only the structure and composition of the assembled 
peptide, but also negatively influences its folding equilibria (Table 4.1). 
A-Ser was also modeled using constraints from NMR. The A-Ser A’BB helix was 




Figure 4.5. Interactions in (a,b) B-Ala,13 (c,d) A-Ala, (e,f) 3-Ala. a, c, and e are models 
of the mutation site . Yellow amino acids are the mutated alanines. The red chain is the 
leading strand, the green chain is the middle strand, and the blue chain is the lagging 
strand in the triple helix. Hydrogen bonds are shown in the yellow dashed lines. b, d, and 
f are schemes of the interactions found in the models. Blue dotted lines are expected 
backbone hydrogen bonds that are formed in the final model. Green dotted lines are 
expected charge pairs that are formed in the final model. Red dotted lines show expected 
interactions that are not formed in the final model. Purple dotted lines are compensating 
interactions that appear in the final models that do not form in the un-mutated model. 
Asterisks denote the isotopically labeled glycines. R1 denotes a lysine side chain, R2 
denotes a glutamic acid side chain, R3 denotes an aspartic acid side chain.
 
formed (Table 4.2). However, A-Ser had additional hydrogen bonds formed that were not 
present in A-Ala, three of which were between the serine OH side chain and the peptide 
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Figure 4.6. Interactions in (a,b) B-Ser,13 (c,d) A-Ser, (e,f) 3-Ser. a,c, and e are models of 
the mutation site . Yellow amino acids are the mutated serines. The red chain is the 
leading strand, the green chain is the middle strand, and the blue chain is the lagging 
strand in the triple helix. Hydrogen bonds are shown in the yellow dashed lines. B, d, and 
f are plots of the interactions found in the models. Blue dotted lines are expected 
backbone hydrogen bonds that are formed in the final model. Green dotted lines are 
expected charge pairs that are formed in the final model. Red dotted lines show expected 
interactions that are not formed in the final model. Purple dotted lines are compensating 
interactions that appear in the final models that do not form in the un-mutated model. 
Asterisks denote the isotopically labeled glycines.  R1 denotes a lysine side chain, R2 
denotes a glutamic acid side chain, R3 denotes an aspartic acid side chain. 
 
backbone (Fig. 4.6). These additional interactions stabilize the triple helix, but also 
constrain the area around the mutation. This can be seen when comparing the A-Ser and 
A-Ala helical twist, where the unconstrained A-Ala has one increase to 130° and quickly 
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Figure 4.7. Helical twist of the peptide systems. The first (leading) chain of the triple 
helix is in red, the second (middle) is in green, and the third (lagging) is in blue. The 
vertical grey area is the mutated region, and the horizontal grey area is the range of 
helical twist in a POG model. The x-axis is the cross-section of the triple helix, starting 
where the lagging strand joins the triple helix. 
 
returns to normal within three cross-sections, however the slightly more constrained A-
Ser has a more diffuse tight twist region that extends up to 125°, but stays elevated and 
more variable for six cross-sections. This more constrained area around the mutation 
would make it more inflexible, leading to the observed lower melting point of 29.5 °C, 
compared to A-Ala at 34.0 °C. 
4.2.3 Triple Mutant Helices 
Unlike A-Ala and A-Ser, 3-Ala and 3-Ser fold into the designed A’A’B’ 
composition and register triple helix. Both have four peaks of equal volume in the 1H,15N-
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HSQC indicating four distinct isotopic labels in the trimer (labeled G1-G4) as expected in 
the A’A’B’ triple helix and analogous to the base system. These systems, however, are 
significantly less stable and less ordered than the base triple helix, having melting points 
of 19 °C and 18 °C respectively. This is lower than either A-Ala or A-Ser, and have the 
lowest melting point of any of the peptides investigated (Table 4.1, Fig. 4.3). 
3-Ala has relaxation values (5.3, 2.4, 3.0, and 4.5) below that of A-Ala (7.7, 8.9, 
11.9, 7.8, and 6.0), and substantially lower than the base triple helix, indicating a very 
disordered region around the mutation. Additionally there is significantly less helical 
population compared to the monomer (0.19 vs. 0.81), lower even than A-Ala (Table 4.1). 
3-Ala also appears to adopt a second minor register as evidenced by the presence of an 
additional set of triple helix peaks in the 1H,15N-HSQC (Fig. 4.2). There are a number of 
possibilities for the alternate register, but because of low folded populations and 
overlapping chemical shifts, further characterization was not possible. 
The model of the 3-Ala A’A’B’ helix was surprisingly well-folded considering 
this helix must incorporate three mutations, with only one lost hydrogen bond, and nine 
formed charge pairs.  The lost hydrogen bonds and charge pairs are in the mutated region, 
which suggests a local disruption that compensates for the mutations. The helical twist of 
A-Ala agrees with this hypothesis with a shift towards larger twist angles, up to 130°, 
around the mutated region extending for five cross-sections. This suggests a perturbed 
and inflexible helix that has difficulty compensating for the three mutations, leading to 
the low melting point. 
3-Ser also retained composition and register control to form the A’A’B’ triple 
helix and also showed a drop in relaxation values (8.3, 4.8, 5.3, and 5.8) when compared 
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to A-Ser indicating greater conformational freedom (Table 4.1). 3-Ser had a fraction of 
trimer to monomer of 0.17 which is similar to A-Ser. This is notable because 3-Ser has 
three mutated amino acids and still is able to fold a comparable amount of triple helices 
as A-Ser which only has one mutation. In the 3-Ser A’A’B’ model, two hydrogen bonds 
and one charge pair is lost, similar to 3-Ala model. However, the serine OH side chains 
contribute an additional four hydrogen bonds, between the adjacent OH groups and with 
the peptide backbone leading to a more constrained mutated region. The helical twist data 
also suggests a more constrained mutated region with values extending over 130° and 
under 80°, with the disruption extending over five cross-sections. This suggests a highly 
perturbed yet inflexible structure, which is compatible with the low melting point. 
4.3 Conclusions 
The designed triple helical systems presented in this paper show that additional 
mutations in the constituent peptide strands of a triple helix result in a drop in melting 
temperature. In all cases the triple helix folding is affected by two major factors: 1) the 
number of mutations in the triple helix and 2) the stability and inflexibility conferred by 
axial charge pairs. The battle between these factors is clear in the A-Ala and A-Ser cases 
where the designed A’A’B triple helix would have ten axial charge pairs and two 
mutations, and nicely satisfy the 2:1 mixing ratio; the triple helix that actually folds, 
however, is the A’BB triple helix, with only five satisfied charge pairs but also only one 
mutation and still a significant portion of unfolded single chains. The number of 
mutations present clearly outweighs the stabilization from charge pairs and therefore the 
mutation directs the composition of the triple helix. In contrast, the 3-Ala and 3-Ser 
systems only have mutated peptides available which forces the formation of a triple helix 
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with three mutations, and the one with the most axial charge pairs, A’A’B’, forms. There 
is no alternative system where fewer mutations could be incorporated. Despite retention 
of the designed composition and register, these are weakly folded systems with the 
largest amount of unfolded peptide. In the folded systems, the charge pairs are in direct 
opposition to the flexibility needed to incorporate the mutations. This tension leads to 
wild variation in the helical twist, and an overall inflexible and unstable region. However, 
when fewer formed charge pairs are present, such as the comparison between B-Ala and 
A-Ala with seven and five formed charge pairs respectively, some of the tension on the 
helix is lifted, allowing for a locally disrupted helix which can normalize over less cross-
sections than the more constrained B-Ala helix. 
4.4 Experimental  
4.4.1 Peptide Synthesis 
Peptide synthesis was performed on an Advanced Chemtech Apex 396 peptide 
synthesizer utilizing standard solid phase peptide synthesis techniques with FMOC 
protecting groups. The peptides were synthesized on a 0.15 mM scale on Rink amide 
MBHA resin (0.37 mmol/gram loading). Deprotection cycles were carried out with a 
25% piperidine in dimethylformamide solution. Coupling cycles employed a 1:4:4:6 ratio 
of resin : amino acid : HATU : diisopropylethylamine (DiEA). For coupling 15N-glycine 
isotopic labels, this ratio was reduced to 1:2:2:3. Acetylation at the N-terminus was 
performed twice with a mixture of resin : DiEA : acetic anhydride (1:10:5) in 
dichloromethane.  A standard cleavage cocktail containing EDT :H2O : TIPS (1:1:0.4) in 
20 mL trifluoroacetic acid (TFA) was performed for three hours to remove the peptides 




Figure 4.8. a) ESI-TOF MS of the purified fractions (Predicted MW [M+H]+= 3324.49, 
Observed 3224.67) and b) HPLC trace of the A-Ala A peptide. c) ESI-TOF MS of the 
purified fractions (Predicted MW [M+K+H]3+= 3279.50, Observed 3279.23) and d) 
HPLC trace of the A-Ser A peptide. 
 
precipitated out with cold diethyl ether. The precipitate was pelleted using centrifugation 
and the ether wash repeated two additional times.  
4.4.2 Peptide purification 
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The peptides were purified with a combination of dialysis and HPLC. Dialysis 
was performed using SpectraPor tubing with a 500-1000 MW cutoff for 3 days. Then the 
solution was diluted to roughly 5 mg of peptide/ 1 mL H2O, and purified through reverse 
phase high pressure liquid chromatography (HPLC). HPLC was performed on a Varian 
PrepStar220 with a Phenomenex Jupiter 4μ Proteo 90 Å column. A gradient of 1% 
acetonitrile (with 0.05% TFA) in water (with 0.05% TFA) was used and the main peak 
was confirmed using electrospray ionization time-of-flight mass spectrometry (ESI TOF-
MS). MS and HPLC spectra (Fig. 4.8). The TFA and acetonitrile were removed via rotary 
evaporation, and the sample was frozen and lyophilized to give pure peptide powder. 
4.4.3 Sample preparation 
Stock solutions of peptides were prepared with Milli-Q water and the pH was 
adjusted to 7 with sodium hydroxide.  For circular dichroism the samples were diluted to 
0.3 mM peptide with 10 mM phosphate, and for NMR the samples were prepared at 3 
mM total peptide concentration and 10 mM phosphate. These solutions were annealed at 
85 °C and allowed to incubate for 1 week at room temperature and 1 week at 4 °C.  
4.4.4 Circular Dichroism Spectroscopy  
A Jasco J-810 spectropolarimeter equipped with a Peltier temperature controller 
was used to record all secondary structure spectra and thermal unfolding studies. Spectra 
were collected between 190 and 250 nm. Melting experiments monitored the maxima 
around 225 nm from 5 – 85 °C at a heating rate of 10 °C/hour, and the minima of the first 
derivative of the melting curve was used to determine the melting temperature of the 
sample. The molar residual ellipticity (MRE), shown as [θ], was calculated from the 
recorded ellipticity using: 
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[!] = !! × ! × !" × 10 
In the equation above θ represents the ellipticity, m is the molecular weight 
(g/mol), c is the sample concentration (M), l is the pathlength (cm) and nr is the number 
of residues in the peptide. The first derivatives of the melting curves are available in Fig. 
4.3, and the melting points are given in Table 4.1. 
4.4.5 NMR Spectroscopy 
All TOCSY, and 1H,15N-HSQC and 1H,15N-NOESY-HSQC experiments were 
performed on a Varian spectrometer of 800 MHz containing a cryogenic probe. The 
nitrogen carrier frequency was set at 110 ppm, while the proton carrier frequency set to 
the water signal. All experiments were performed at 10 °C. Chemical shift assignments of 
residues were made using TOCSY spectra. For TOSCY spectra 1120 x 512 complex 
points and 128 scans were acquired; the mixing time was 100 ms and sweep width 12 
kHz in both dimensions. The 1H,15N-HSQC were collected with 1040 x 256 complex 
points for a total of 16 scans. A sweep width of 10 kHz in the proton and 2432 Hz in the 
nitrogen dimension was used. To compare relative peak volumes of folded and unfolded 
states, for each 1H,15N-HSQC of an AAB heterotrimer the total peak volume was set to 1. 
Because of the difference in the relaxation rate of the monomer and folded helix no 
quantitative relationship between the populations can be determined from this ratio, but a 
general comparison between the mutation types may be made (Table 1). A 2D version of 
the 3D 1H,15N-NOESY-HSQC collected with 100 ms mixing time, 64 scans, 1200 x 256 
complex points; the spectral window was 12 kHz in the direct dimension and 12 kHz for 
the indirect dimension. 15N relaxation experiments were performed on 3 mM samples as 
previously described on a 500 MHz Varian spectrometer.13 Data was processed and 
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analyzed using NMRdraw,15 and ccpnmr16 processing suites. Additional spectra including 
1H,15N-NOESY-HSQCs and TOCSY, along with a discussion of the assignment process 
are available in Appendix 2. 
4.4.6 Molecular Modeling 
Models were created by first preparing a basic structure with the appropriate 
sequence, and expected composition and register. For the B-Ala, B-Ser, 3-Ala and 3-Ser 
helices an AAB composition and register was used. For A-Ala and A-Ser an ABB 
composition and register was used. Constraints were created for the heterotrimers from 
their assigned 1H,15N-NOESY-HSQC spectrum. These constraints were used to model the 
heterotrimers using the Rosetta Relax application.17, 18 Negative constraints were created 
for situations where constraints were present in the base structure, but not the mutated 
structure. Negative constraints were not used for the three chain mutants because their 
initial structure deviated significantly from the base structure. Positive correlations were 
set for 0-4 Å and negative from 6-10 Å. Once a set of structures was created, they were 
analyzed for compliance to the constraints. Positive correlations were considered satisfied 
if they were below 5 Å and negative correlations were considered satisfied if they were 
above 5 Å. The most compliant structure was then iterated until all constraints were 
satisfied. If any constraints were still unsatisfied after multiple iterations the standard 
deviation of that constraint was decreased to increase the penalty for longer distances. 
The final structures presented here are compliant to all NMR constraints. The constraints 
used are available in Appendix 1.  
4.4.7 Helical Twist 
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Figure 4.9. Panel A illustrate two adjacent triads composed of the three α carbons in each 
cross section. The displacement between the centroids is shown as d and the radius as r. 
Panel B shows the two triad centroids overlaid to illustrate the tilt angle between them. In 
panel C, the triads are viewed from above and have been tilted such that they lie in the 
same plane. Illustrated are the angles of interest in each respective color green, turquoise, 
and white. 
 
A program was written in Java with a J/Link to Mathematica19 to perform the 
twist measure calculations in this study. For each residue the coordinates of the alpha 
carbon were considered for the purpose of conducting calculations. The program was 
used to extract alpha carbon coordinates from two adjacent triads on the helical axis and 
perform a series of transformation calculations on these coordinates. The calculations run 
to assess the measure of twist along the helical axis were done by taking cross-sections of 
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the helix, perpendicular to the helical axis, containing an amino acid from each of the 
three strands of the triple helix (illustrated in Fig. 4.9). This ensures that each of the 
amino acid residues in a cross section will occupy a different position in the conventional 
Xaa-Yaa-Gly structure of a collagen triple helix due to the staggered nature of helical 
collagen. From here, a cross section containing Xaa, Yaa, and Gly position amino acids 
will be referred to as a triad to differentiate from a conventional Xaa-Yaa-Gly triplet. The 
coordinates of the alpha carbons of each residue were used to construct the coordinate 
matrices for each triad. 
The Kabsch twist values 21 were obtained in a similar manner to a recent report 22 
in which he utilized the CNS package which uses the Kabsch least-squares fitting 
algorithm to calculate a least-squares superposition matrix and translation vector from 
which he extracted helical twist and translation. In our study however, we utilized a script 
in Java to call a Mathematica notebook to calculate the covariance matrix of two triads 
adjacent on the helical axis. Mathematica was then used to perform a Singular Value 
Decomposition (SVD) on the covariance matrix and the result was used to calculate the 
optimal rotation matrix (U) according to the Kabsch algorithm. From this the translation 
vector ! can be extracted as follows: 
 
!"#:    ! = ! ! !! ! !! ℎ !  
! =  ±  ℎ − !! − !! − !  
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and the angle of rotation θ is embedded in the rotation matrix U as follows: 
!"#:    ! =  !!!  
  ! =  !! 1− !"# ! + !"# ! !"(1− !"# !)− ! !"# ! !" 1− cos! + ! sin!!" 1− cos! + ! sin! !! 1− !"# ! + !"# ! !"(1− cos!)− ! sin!!"(1− cos!)− ! sin! !" 1− cos! + ! sin  !! 1− !"# ! + !"# !  
or, more simply: 
!"#$% ! = 1+ 2 cos! 
Applying this optimal rotation matrix and translation vector to the points in one triad will 
not exactly overlay with the points of the adjacent triad due to variations in the collagen 
helix due to variables like the identity of the adjacent triads, the position of each triad in 
the triple helix, etc. 
 The radius and displacement values were calculated with respect to the centroid of 
each triad. The centroid was calculated by taking the average of all of the x, y, and z 
coordinates in a triad. The displacement values are the distance from each residue to the 
centroid and the radius is the average of these three values. 
 The translation between triads was calculated as the distance between the 
centroids of adjacent triads. The accompanying unit vector is the unit vector the points 
from the first centroid to the next and was calculated by taking the difference of each set 
of coordinates and dividing by the magnitude of the translation. 
 The angle of tilt between two adjacent triads was calculated by first shifting the 
centroid of each triad to the origin by subtracting the coordinates of the centroid from the 
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Figure 4.10. Illustration of the intersection of planes created by each triad. 
coordinates of each individual alpha carbon. This ensured that the centroids of both triads 
were coincident with one-another and that there exists a single line at the intersection of 
the planes created by each triad as shown in Figure 4.10.  The unit vector pointing in the 
direction of this line was calculated by taking the cross product of the vectors that point 
perpendicular from each triad’s plane. These vectors were obtained by using 
Mathematica to solve for the equation of the plane through the alpha carbons of each 
triad and using the x, y, and z coefficients as the coordinates for these vectors. The tilting 
angle between the planes was calculated according to the following: 
!"# !"#!"$%&'()*# !"#$%&' ! !"# ! 
cos! = !∙!! ∗ !             eq. 5 
For the twisting angle to be calculated, first the tilting transformation had to be 
done to the second triad. This was done by first formulating a rotation matrix of the same 
form as equation 3 by using the unit vector of the line of intersection and the angle 
calculated in equation 5 and then left multiplying each set of coordinates of the second 
triad by this rotation matrix. The angle of twist was then obtained by measuring the angle 
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between the coordinates of each residue on the first triad, the centroid, and the 
coordinates of the corresponding residue on the second triad. 
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Chapter 5: Conclusions 	
Collagen is a ubiquitous protein that functions as a scaffold, signaling protein, and 
adhesion point for cells. Much is known about collagen’s functions, but less is known 
about the supramolecular forces affecting the triple helix. I have presented research that 
elucidates the relationship of charge pairs on stability and have given insight to the 
impact of mutations on composition and register control in the triple helix.  
In a canonical collagen triple helix, three peptides self-assemble into a supercoiled 
motif with a one amino acid offset between the peptide chains. Design of triple helices 
that contain more than one residue offset is lucrative, as it leaves the non-covalent 
interactions unsatisfied at the termini and renders the termini “sticky” to further self-
assemble into collagen-like nanofibers. In the second chapter I, with coworkers, used 
lysine−glutamate axial salt-bridges to design a heterotrimeric collagen triple helix, ABC-
1, containing a non-canonical offset of four residues between the peptide chains. A 
second heterotrimer, ABC-2, also stabilized by axial salt-bridges, was designed 
containing a canonical one-amino-acid offset to facilitate comparison of structure and 
stability by CD and NMR. ABC-1 and ABC- 2 demonstrate our ability to modulate chain 
offset in a collagen triple helix. These “stickier” structures require a very delicate balance 
of stabilizing charge pairs in the offset helix, and destabilizing interactions in the blunt 
helix because both species will be possible in solution. This lays the groundwork to 
design longer, and therefore stickier, offsets allowing access to a new class of collagen-
related nanostructures. 
In Chapters 3 and 4 I discussed Osteogenesis imperfecta (OI) which is a disease  
caused primarily by mutations of glycine in the standard (Xaa-Yaa-Gly)n repeat of a type 
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I collagen triple helix. Type I collagen is an AAB heterotrimer, which means that, 
depending on whether the A or B chain is mutated, the glycine substitution will appear 
once or twice. In Chapter 3, designed axial charged pairs were used to self-assemble an 
AAB triple helix with controlled composition and register. Then a single glycine of the B 
chain with alanine, serine, valine, aspartate, or arginine was substituted and assessed for 
the impact on the structure and folding of this OI mimic by CD, NMR, and restraint-
guided modeling. It was found that alanine and serine substitutions are tolerated, resulting 
in localized disruptions to the triple helix structure, while bulkier amino acids result in 
alternatively folded structures. Models guided by NMR of the alanine and serine 
substitutions show composition and register control with the loss of 5 and 2, respectively, 
hydrogen bonds around the mutation site, and wide variation in the helical twist due to 
the mutation and the conformational demands of the charge pairs. Larger amino acids, 
such as valine, aspartate, and arginine, result in loss of composition and register control, 
where the homotrimers of the A peptide folds instead of the designed AAB helix.  This 
work demonstrates the potential of axial charged pairs to control the structure of low 
stability triple helices and also helps to elucidate the structure and folding challenges 
associated with OI-type mutations in collagen.  
In Chapter 4 I presented a series of triple helices with mutations to a composition-
 and register-controlled AAB helix where one of the requisite glycines in the A chain of 
the triple helix is changed to serine or alanine. There is a loss of compositional control 
when the A chain is mutated, resulting in an A′BB composition that minimizes the 
number of mutations included in the triple helix. This demonstrates that the stabilization 
generated by charge pairs is insufficient to compensate for the destabilization of the 
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double mutation. A combination of NMR and molecular modeling revealed that only one 
hydrogen bond was lost in each of the alanine and serine cases and all possible charge 
pairs were formed. However, when both A and B chains are mutated and no non-mutated 
peptide chains are available, the designed A′A′B′ composition is reestablished and the 
resulting triple helix is surprisingly well folded while compensating for three mutations. 
This work shows the ability of the mutations to influence and alter the composition and 
register of the collagen triple helix. 
Globally, the OI studies are still at a low level of relevance to biological systems. 
In order to increase the relevance of the model systems they need to be able to integrate 
sequences where the mutations occur in natural collagen. However, the natural sequences 
disrupt the composition and register control, which can be exacerbated by the mutations. 
In the beginning of this project five alternate sequences of the model were attempted, 
each containing natural sequences, however these models were either unable to fold, or 
would fold in the incorrect composition and register with all mutations. While our model 
triple helical systems give information about the composition and register created, that 
control is artificial, and the twist created is a combination of both the mutation and charge 
pairs.  
Future studies may be able to overcome these difficulties when better 
understanding of pairwise interactions in collagen is gained allowing for more effective 
design of the host peptide sequences. Alternatively, bacterial expression of a natural 
sequence with the specific mutation could be used study the specific effect of that 
mutation, but heterotrimeric, bacterially expressed peptides with natural sequences have 
not been shown to exhibit composition control. While the designed triple helices used in 
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my study are a step in the direction of biological relevance much improvement is needed 
until biological and clinicial significance, not just supramolecular folding principles, can 
be ascertained from the results. 
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45B 2HA 45B positive 1 
45B 1HA 45B positive 1 
45B 1HB 72C positive 1 
45B 1HD 14A positive 1 
75C HA 74C positive 1 
75C H 76C positive 1 
75C 1HA 75C positive 1 
75C 1HA 18A positive 1 
75C 1HD 19A positive 1 
75C 1HD 44B positive 1 
75C 1HA 45B positive 1 
66C HA 65C positive 1 
66C 2HA 66C positive 1 
66C 1HA 66C positive 1 
66C 1HD 67C positive 1 
66C 1HD 37B positive 1 
66C 2HB 65C positive 1 
66C 1HB 37B positive 1 
66C 1HB 65C positive 1 
66C 1HD 38B positive 1 
15A 1HA 15A positive 1 
15A 2HA 45B positive 1 
15A 1HD 43B positive 1 
15A 1HB 72C negative 0.75 
15A 2HB 72C negative 0.75 
15A 3HB 72C negative 0.75 
45B HA 72C negative 0.75 
45B HA 74C negative 0.75 
15A HA 44B negative 0.75 
15A HA 16A negative 0.75 
15A HA 71C negative 0.75 










75C 1HB 74C positive 1 
75C 1HA 75C positive 1 
75C 1HB 76C positive 1 
75C 2HB 76C positive 1 
75C 1HD 19A positive 1 
15A 2HB 72C positive 0.5 
15A 1HD 14A positive 1 
15A 1HA 15A positive 1 
66C H 8A positive 1 
66C HA 8A positive 1 
66C 1HB 8A positive 1 
66C 1HD 8A positive 1 
66C 1HB 65C positive 1 
66C 1HA 66C positive 1 
66C 2HA 66C positive 1 
45B H 72C positive 0.5 
45B HG 72C positive 1 
45B 1HD 73C positive 1 
45B HA 74C positive 1 
45B 1HB 74C positive 0.5 
45B H 75C positive 1 
45B 1HA 75C positive 0.25 
45B 1HA 15A positive 1 
45B H 44B positive 1 
45B HA 44B positive 1 
45B 1HA 45B positive 1 
45B 2HA 45B positive 1 
66C HA 37B negative 1 
66C HA 67C negative 1 
66C HA 7A negative 1 
75C HA 73C negative 1 
75C HA 77C negative 1 
75C HA 19A negative 1 
15A HA 71C negative 1 
15A HA 73C negative 1 
15A HA 74C negative 1 
45B HA 47B negative 1 










45B HA 44B positive 1 
45B 2HA 45B positive 1 
45B 1HA 45B positive 1 
45B 1HB 44B positive 1 
45B 1HD 14A positive 1 
75C HA 74C positive 1 
75C 1HA 75C positive 1 
75C HA 16A positive 1 
75C 1HA 45B positive 1 
75C 1HB 74C positive 1 
75C 1HB 44B positive 1 
75C H 46B positive 1 
75C H 18A positive 1 
66C HA 65C positive 1 
66C HA 8A positive 1 
66C 2HA 66C positive 1 
66C 1HA 66C positive 1 
66C 2HD 67C positive 1 
66C 1HD 7A positive 1 
66C 1HD 67C positive 1 
66C 2HB 65C positive 1 
66C 1HB 65C positive 1 
66C H 8A positive 1 
66C H 36B positive 1 
15A HA 44B positive 1 
15A 1HA 72C positive 1 
15A 2HA 45B positive 1 
15A 1HD 43B positive 1 
15A 1HB 73C positive 1 
15A 2HB 44B positive 1 
15A 1HB 44B positive 1 
66C 1HA 9A negative 1 
66C HA 35B negative 1 
15A HA 17A negative 1 
15A HA 74C negative 1 
45B 1HA 18A negative 1 
75C 1HA 15A negative 1 
75C HA 47B negative 1 










15A 1HD 14A positive 1 
15A 1HA 45B positive 1 
15A 1HA 15A positive 1 
15A HA 14A positive 1 
15A H 16A positive 1 
45B H 46B positive 1 
45B H 15A positive 1 
45B HA 44B positive 1 
45B 1HA 15A positive 1 
45B 1HA 45B positive 1 
45B 2HA 45B positive 1 
45B 1HD 73C positive 1 
45B 1HB 44B positive 1 
45B 2HB 44B positive 1 
75C 1HB 74C positive 1 
75C 1HA 75C positive 1 
75C 2HA 75C positive 1 
75C H 46B positive 1 
36B 1HB 35B positive 1 
36B 2HB 35B positive 1 
36B 1HD 7A positive 1 
36B 1HD 37B positive 1 
36B 1HA 36B positive 1 
36B 2HA 36B positive 1 
36B HA 35B positive 1 
66C 1HB 65C positive 1 
66C 2HB 65C positive 1 
66C 1HB 7A positive 1 
66C 1HD 7A positive 1 
66C 1HD 67C positive 1 
66C 1HA 66C positive 1 
66C 2HA 66C positive 1 
15A HA 13A negative 0.5 
45B HA 16A negative 0.5 
75C HA 73C negative 0.5 
66C HA 64C negative 0.5 
36B HA 64C negative 0.5 











75C HA 74C positive 1 
75C 2HB 74C positive 1 
75C 1HB 74C positive 1 
75C 2HA 75C positive 1 
75C 1HA 75C positive 1 
75C 1HB 16A positive 1 
75C 2HA 45B positive 1 
75C 1HB 46B positive 0.5 
15A HA 14A positive 1 
15A 1HA 15A positive 1 
15A 1HD 43B positive 1 
15A 1HA 45B positive 1 
36B 1HB 7A positive 1 
36B HA 8A positive 1 
36B HA 35B positive 1 
36B 1HB 35B positive 1 
36B 2HB 35B positive 1 
36B 1HA 36B positive 1 
66C 1HD 7A positive 1 
66C 2HB 7A positive 1 
66C H 8A positive 1 
66C HA 65C positive 1 
66C 2HB 65C positive 1 
66C 1HB 65C positive 1 
66C HA 35B positive 1 
66C 2HA 36B positive 1 
66C 1HD 37B positive 1 
66C 1HA 66C positive 1 
66C 2HA 66C positive 1 
45B 1HD 73C positive 1 
45B 1HB 73C positive 1 
45B 1HD 14A positive 0.5 
45B 1HG 14A positive 1 
45B 1HA 15A positive 1 
45B H 16A positive 1 
45B HA 44B positive 1 
45B 1HB 44B positive 1 
45B 2HB 44B positive 1 
45B 1HA 45B positive 1 
45B 2HA 45B positive 1 
45B H 46B positive 1 
66C HA 67C negative 1 
66C 1HA 6A negative 1 
36B HA 5A negative 1 
75C 1HA 15A negative 0.5 
75C 1HA 48B negative 1 
45B HA 47B negative 1 
15A HA 71C negative 1 
15A HA 73C negative 1 











45B 1HA 45B positive 1 
45B 2HA 45B positive 1 
45B HA 44B positive 1 
45B 1HD 73C positive 1 
45B 1HG 14A positive 1 
45B 2HG 14A positive 1 
45B 1HB 44B positive 1 
45B 1HD 14A positive 1 
15A 1HA 45B positive 1 
15A 1HA 15A positive 1 
15A 2HA 15A positive 1 
15A 1HB 42B positive 1 
15A H 42B positive 0.5 
15A H 44B positive 1 
15A 1HB 43B positive 1 
15A 1HD 44B positive 1 
15A HA 14A positive 1 
15A 1HD 43B positive 1 
75C 1HA 45B positive 1 
75C 1HA 75C positive 1 
75C 2HA 75C positive 1 
75C H 76C positive 1 
75C HA 74C positive 1 
75C 1HB 74C positive 1 
75C 1HD 19A positive 1 
75C 2HB 74C positive 1 
66C 1HA 66C positive 1 
66C 2HA 66C positive 1 
66C HA 65C positive 1 
66C 1HB 65C positive 1 
66C 1HA 9A positive 1 











15A H 16A positive 1 
15A HA 14A positive 1 
15A 1HA 15A positive 1 
15A 1HB 72C positive 1 
15A 1HD 14A positive 1 
15A 1HG 14A positive 1 
75C 1HA 75C positive 1 
75C HA 74C positive 1 
75C H 76C positive 1 
75C 1HB 74C positive 1 
75C 2HA 75C positive 1 
66C 1HA 66C positive 1 
66C HA 65C positive 1 
66C 1HB 65C positive 1 
66C 2HB 65C positive 1 
66C H 8A positive 1 
66C 1HD 67C positive 1 
66C 2HD 67C positive 1 
66C 1HB 37B positive 1 
45B 1HA 45B positive 1 
45B 2HA 45B positive 1 
45B HA 44B positive 1 
45B 1HA 75C positive 1 
45B 1HB 16A positive 1 
45B 1HD 44B positive 1 
      Table A1.7. Constraints used for 3-Ser modeling 
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Appendix 2: Supporting NMR Spectra 
 
A2.1 Chapter 2 
	
 
Figure A2.1. 1H,15N-HSQC spectra of individual, binary and ternary peptide mixtures 
used for testing combinations ofA1,BandC1. 
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Figure A2.2. 1H,15N-HSQC spectra of individual, binary and ternary peptide mixtures 
used for testing lateral combinations of A2, B and C2.
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Figure A2.3. Amide region of the 1H,1H-NOESY spectrum of ABC-1 (green) and ABC-
2 (red) indicating the similarity in the general cross-peak pattern and chemical shift. The 
interpeptide E(NH)-K(Hε) and E(NH)- K(Hε’) cross peaks are also depicted. 
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Figure A2.4. 1H,15N-HSQC spectra of individual, binary and ternary peptide mixtures 
used for testing A1, B and C1’. 
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A2.2 Chapter 3 
 
 
Figure A2.5. TOCSY figure showing connectivity for Gly3 in the Base system
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Figure A2.6. TOCSY figure showing connectivity for Gly3 in the B-Ala system.
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Figure A2.7. TOCSY figure showing connectivity for Gly3 in the B-Ser system.
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Figure A2.8. TOCSY figure showing connectivity for folded proline residues.
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Figure A2.9. TOCSY figure showing connectivity for folded hydroxyproline residues.
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Figure A2.10. TOCSY figure showing connectivity for folded lysine residues.
	 119 
 
Figure A2.11. TOCSY figure showing connectivity for folded aspartate residues.
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Figure A2.12. TOCSY figure showing connectivity for folded glutamate residues.
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A2.3 Chapter 4 
 
 
Figure A2.13. TOCSY figure of the AAB base peptide showing connectivity for Gly3 in 




Figure A2.14. TOCSY figure of the AAB base peptide showing connectivity for Gly3 in 




Figure A2.15. TOCSY figure of the AAB base peptide showing connectivity for Gly3 in 




Figure A2.16. TOCSY figure of the AAB base peptide showing connectivity for folded 
proline residues. Chemical shifts are shown by red lines, and relevant correlations are 
circled. With the mixing time used during acquisition (85 ms) it was not possible to see 
direct CβH to CαH correlations- for shorter mixing times (25 ms) this cross peak was 
observed though overlapped with other peaks in the alpha proton region. Though not 
directly coupled, with the longer 85 ms mixing time it was possible to observe a CδH to 
CαH cross peak. 
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Figure A2.17. TOCSY figure of the AAB base peptide showing connectivity for folded 
hydroxyproline residues. Chemical shifts are shown by red lines, and relevant 
correlations are circled. 
	 126 
 
Figure A2.18. TOCSY figure of the AAB base peptide showing connectivity for folded 




Figure A2.19. TOCSY figure of the AAB base peptide showing connectivity for folded 




Figure A2.20. TOCSY figure of the AAB base peptide showing connectivity for folded 
glutamate residues. Chemical shifts are shown by red lines, and relevant correlations are 
circled.		
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